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ABSTRACT
BACKGROUND AND AIMS:
Blood transfusion is a common intervention in critically ill surgical
patients, especially Burns patients. But transfusions have potentially life
threatening risks. The aim of the study was to evaluate the appropriateness of
various blood components, utilized in Burns patients and also to evaluate the
relationship between age of red blood cells and wound healing.
MATERIALS AND METHODS:
Burns patient who were more than 16 years, with 15 – 40% Total body
surface area burns and had survived treatment were included for a period of one
year (September 2014 – August 2015). New York State health guidelines for RBC
transfusion in Burns, Baxter’s original Parkland formula and platelet transfusion
thresholds given by the American Association of Blood Banks (AABB) were used
to categorize appropriate transfusions from inappropriate transfusions. Length of
hospital stay was taken as the measurable outcome for wound healing and the
factors influencing Length of stay were analysed.
RESULTS:
A total of 122 burns patients who fulfilled the inclusion criteria were
followed. 85 patients received 308 red cell units of which 64% were appropriate.
114 patients were transfused with 441 fresh frozen plasma units of which 47%
were appropriate. One patient was transfused with platelet concentrate and all
patients, who had their platelet count more than 10,000/µL, were not transfused.
The factors found to significantly increase the length of stay included the
APACHE II score at admission, Red cell transfusions, surgical procedures and
wound infections. The factors not significantly influencing Length of stay were
age of the burns patient, sex and storage age of red cells.
CONCLUSION:
In our study, 64% of red blood cell transfusions and 47% of FFP
transfusions were appropriate. As the storage age of red blood cells had no
significant influence on length of stay, there is no rationale in ordering fresher
whole blood to aid in wound healing. Length of stay for burns patients
significantly increases following blood component transfusion. Successful
outcome of burns patients purely depends on proper wound care, along with
appropriate use of fluids and blood components.
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1INTRODUCTION
Red blood cell transfusion is a common intervention in intensive care
units with approximately one third of critically ill patients receiving a blood
transfusion at one time or another during their stay.1 A significant number of
surgical patients are exposed to the potential risks of blood transfusion where
hemolytic transfusion reactions and transfusion-transmissible infections can be
life-threatening.2
Tolerance to anemia is highly dependent on the volume status of the
patient, physiological reserve and the dynamics of anemia, as normovolemic
anemia is better tolerated than anemia in hypovolemic states.1
The criteria for optimal anemia management are not clearly defined
even though transfusions are more prevalent in ICU patients. The transfusion
trigger of hematocrit 30% or hemoglobin 10 gm/dL was first suggested in
1942, which is still being followed in many centers, even though clinical trials
over the past two decades have shown equivalent outcomes with a conservative
transfusion threshold of hemoglobin level of 7 gm/dL, in critically ill patients. 3
While India has an estimated annual blood requirement of 12 million,
the annual collection stands at 9.8 million, of which 84 % are collected from
voluntary donors.4 So, adequate inventory of blood is still a significant and
chronic concern which further compounds liberal transfusion practice.2
The cost-effective approach to reduce the use of allogeneic blood
transfusion is to improve appropriateness of transfusions, as new guidelines
recommend that decisions to transfuse be based primarily on clinical
2assessment of individual patients rather than arbitrary hematocrit thresholds.
The rates of inappropriate transfusions have varied from 0.3 to 49.6% because
of the differences in criteria used to define appropriate and inappropriate
transfusions.3
Burns patients suffer possibly the greatest initial hemodynamic and
metabolic stress of all the surgical critically ill patients with the duration of
illness lasting for weeks and months. Conditions that necessitate transfusions
related to anemia in burns patients are not clearly defined.5
This study was undertaken to find out the appropriateness of blood
usage pattern in Burns patients which will help the Burns treatment team to
utilize the invaluable resource appropriately, predict future blood demand and
help maintain transfusion inventory for specialized burns units.
3AIMS AND OBJECTIVES
AIM:
To evaluate the appropriateness of blood component utilization in Burns
patients admitted in Burns ward, Kilpauk Medical College and Hospital,
Chennai, Tamilnadu.
OBJECTIVES:
- To evaluate the appropriateness of various blood components utilized in
Burns patients.
- To evaluate the relationship between age of red blood cells and wound
healing.
4REVIEW OF LITERATURE
Skin:
Skin is the largest organ in the human body, weighing about 6 to 10 kg
with surface area of 1.5 to 2 square meters in an adult male. Epidermis is
thinner over eyelids and thicker over soles of feet while dermis is thickest over
the back. Infants, children and the elderly have thinner dermis making them
more prone for deeper burn injuries.6
Skin has varied functions like protection of underlying tissues,
prevention of water loss, regulation of body temperature, synthesis of vitamin
D and also as a sensory organ. Skin also takes part in immunological function
with its rich supply of Langerhans cells, Keratinocytes, Lymphocytes and Mast
cells.7
As skin functions as a barrier to microbial invasion, the size of burn
injury correlates well with burns wound infection and systemic infection.6
Burns:
Burns is caused by overheating of body tissues above the critical
temperature, leading to tissue damage.7 Burns is a major cause of morbidity
and mortality worldwide which rises with increasing burned surface area and
age. Even small burns can become fatal in the elderly.8
Burns are classified as first, second and third degree but it is common to
find all three types within the same burns wound, where depth changes with
time, especially if infection occurs.
5Table 1: Characteristics of various degrees of burns: 8
Depth of burns Characteristics Cause
First degree burns ? Erythema
? Pain
? Absence of blisters
? Sunburn
Second degree
burns
(partial thickness)
? Red or mottled
? Swelling and
blisters
? Painful
? Contact with hot
liquids
? Flash burns
Third degree
burns
(full thickness)
? Dark and leathery
? Dry
? Sensation only at
edges
? Fire
? Electricity or
lightning
? Prolonged exposure
to hot liquids/objects
Serious burns requiring hospitalization:8
? Greater than 15% burns in an adult
? Greater than 10% burns in a child
? Any burns in the very young, the elderly or the infirm
? Any full thickness burns
? Burns of special regions: face, hands, feet or perineum
? Circumferential burns
? Inhalation injury
? Associated trauma or significant pre-burns illness: e.g. diabetes
Burns involving the face, airway or genitalia are classified as major burn
injuries regardless of % Total Body Surface Area burns (% TBSA) affected.9
6First degree and superficial second degree burns are usually treated with
daily dressing changes, medications, blood products like fresh frozen plasma
and packed red cells along with protein and vitamin enriched diet and do not
need surgical intervention. Deep second and third degree burns generally
require surgeries like escharotomy, wound debridement, skin grafts and
amputation.10
Burns in the world:
An estimated 265,000 deaths occur in the world every year caused by
burns11 of which Southeast Asia contributes to nearly one half of the total
number of fire related burn deaths worldwide.12 Non- fatal burns are a leading
cause of morbidity.11
Burns in India:
India, with over a billion population, has an estimated annual burns
incidence of 6-7 million, thus accounting as the second commonest cause of
injuries after road traffic accidents. Even though 90% of burns are preventable,
10% of these burn injuries are life-threatening and 50% of the hospitalized
patients die of their injuries. Nearly 70% of burns victims are in the 15 to 40
age group who are most productive but belong to poor socioeconomic status.
National data on burns are scarce as it is not a notifiable disease and central
registry is nonexistent.13 Burn injuries continue to be a problem due to poor
access to medical facilities and lack of specialist doctors.14
The National Programme for Prevention of Burn Injuries (NPPBI) has
been initiated in India to reduce the incidence of burns and to effectively utilize
7available resources for standardized treatment delivery. The programme has
three components, namely, Preventive programme, Burns injury management
programme and Burns injury rehabilitation programme. For burns injury
management, existing medical facilities are upgraded and utilized while
capacity building will be made in non-existent facilities.13
Magnitude of the Burns problem:
According to National Crime Records Bureau (NCRB) reports, total
accidental deaths in 2013 were 4,00,517 of which total deaths due to accidental
fires are 22,177 (6.6%) with electrocution adding another 10,218 (2.6%) of
accidental deaths. Tamil Nadu accounts for 8.3% and thus shares a larger
percentage of accidental deaths, at third place in our country. 15
Deaths due to Fire/Self-immolation account for 7.4 % of all suicides
(1,34,799) in India, being the third prominent means of committing suicides.
Tamil Nadu accounts for 12.3% of all suicides in India, the second highest after
Maharashtra. The share of female victims was higher (63.1%) in suicides by
Fire/Self-immolation.16
Illiteracy, high poverty and crowding in urban areas contribute to unsafe
living conditions. Inadequate access to health care facilities cause a delay in
presentation to specialized burns units.17 The costs of treatment in specialized
burns units are very high which further restricts the common man’s reach.14
Children and their parents should be educated about fire safety, storage
and safe handling of flammable fluids and gases (especially cooking stoves)
and first aid for flame burns and scalds.17
8Total Body Surface Area burns (TBSA) calculation:
Burns size is assessed using the Wallace rule of nines or the Lund and
Browder chart.18,19
Fig 1: % TBSA calculation based on rule of nines 18
Wallace rule of nines is a good, quick way of estimating medium to
large burns in adults, though it is not accurate in children. The body is divided
into areas of 9% and the % total body surface area burns is calculated. 18
9Fig 2: % TBSA calculation based on Lund and Browder chart18
This chart, if used correctly, is the most accurate method. It compensates
for the variation in body shape with age and therefore can give an accurate
assessment of burns area in children.18
10
Mortality increases as the degree of burns and total body surface area
burns increase i.e. 0.25% mortality risk with less than 10% TBSA, 5.4% risk
with 20-39% TBSA and 96.6% risk for >90% TBSA. Mortality was observed
more in greater than 40% burn injury.20
Burn injury pathogenesis:
Burn injury evolves in two phases, a burns shock phase followed by a
hypermetabolic phase. There is an increased microvascular permeability,
vasodilatation, vascular stasis and reduced cardiac output resulting in massive
edema formation in both injured and non-injured tissues, within 6-8 hours of
burns. This shock phase is followed by a massive surge in catecholamines and
corticosteroids, greater in non-burned tissues, which results in a
hypermetabolic state with increased myocardial oxygen consumption, systemic
hypertension, muscle degradation, insulin resistance and liver dysfunction.9
Burns tissue release inflammatory mediators like histamine,
prostaglandins, kinins, thromboxane and nitric oxide, which increase in the
early hours after burn injury and result in increased capillary permeability and
local edema. Subsequent reperfusion results in reactive oxygen species and
toxic cell metabolites which propagate immune response.9
Hyperventilation occurs in hypermetabolic phase and persists till wound
closure. Proteins and amino acids are mobilized to meet the increased
metabolic needs resulting in significant loss of lean body mass, which further
impairs immune function and wound healing.9
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Inhalation Injury:
Inhalation injury of the lung is proportional to the depth and extent of
TBSA and along with cutaneous burns, increases fluid resuscitation
requirements, pulmonary complications and overall mortality. This injury can
be divided into three classes: 1) heat injury restricted to upper airway above the
glottis, which lead to massive edema and obstruction, 2) local chemical
irritation throughout the respiratory tract, which damage type II pneumocytes
and impairs surfactant production and 3) systemic toxicity due to carbon
monoxide or cyanide, by compromising oxygen delivery. Mucus and cellular
debris form casts, which can obstruct moderate size airways when mucosa
sloughs. 6, 21
History of entrapment in a closed space, facial burns, symptoms of
respiratory distress with the presence of singed nostril hairs and carbonaceous
sputum point to probable inhalation injury.9, 22, 23 As the oropharynx and
nasopharynx dissipate heat effectively, thermal injury is primarily restricted to
airway structures above the vocal cords, unless steam is inhaled.9
Fluid loss in Burns:
Before recognition of the magnitude of fluid shifts and massive fluid
requirement in Burns, failed resuscitation was the leading cause of death. The
primary goal of burn resuscitation is to maintain adequate tissue perfusion and
prevent ischemic injury, especially acute renal failure.24 Burns patients suffer
possibly the greatest initial hemodynamic and metabolic stress and duration of
their critical illness can last from weeks to months. 5
12
Loss of fluid in burn injury was the result of active transport of water
across the capillary wall rather than increased capillary permeability. This
increased permeability is also seen in areas distant from burns site.25, 26
Disrupted capillary integrity allows for rapid equilibration of water, inorganic
solutes and plasma proteins between intravascular and interstitial spaces which
lead to intravascular hypovolemia and hemoconcentration that are maximal at
12 hours postburns.27
Leakage and accumulation of plasma proteins in the extravascular
compartment contribute significantly to tissue edema formation. It takes about
12 hours for the protein leakage to cease significantly.28
Patients with burns involving less than 20% TBSA for adults and 10-
15% TBSA for children can be treated successfully with oral fluids alone. 28
Under resuscitation leads to decreased perfusion, acute renal failure and death
while over resuscitation leads to “fluid creep” which in turn leads to worsening
edema, Acute Respiratory Distress Syndrome and multiple organ dysfunction 27
Crystalloid solutions alone are sufficient to acutely resuscitate most
uncomplicated burns patients up to 20 to 25% TBSA. Parkland described the
use of isotonic crystalloid solution, Ringer’s Lactate, at a dose of 4 ml/kg/% of
TBSA during the first 24 hour post burn to maintain a urine output of 30 to 50
ml/hour. One half of the total fluids calculated are administered in the first 8
hours and the rest is administered over the next 16 hours. 24 Ringer’s Lactate
contains 130 mEq/L of sodium, which is slightly hypotonic, but it effectively
treats both hypovolemia and extracellular sodium deficits caused by thermal
injury. 27
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Adults and children with burns greater than 20% TBSA should undergo
formal fluid resuscitation to maintain a urine output of 0.5-1.0 ml/kg/hr in
adults and 1.0-1.5 ml/kg/hr in children, [a mean hourly urine output of
approximately 50 mL/hr in the first 24 hours and 100 mL/hr during the next 24
hours]. 27, 29 Urinary output is an unreliable guide for patient’s hydration status
> 48 hours after burn injury, as respiratory water loss, osmotic diuresis by
glucose and hormonal derangements contribute to increased fluid losses despite
an adequate urine output.30
The addition of colloids after the first 12-24 hours post burns, may
decrease overall fluid requirements, as capillary integrity is sufficiently
restored at about 24 hours post burns. 27 The main colloids used for burns
resuscitation are Human albumin, the most oncotically active colloid and Fresh
Frozen Plasma (FFP), which contains clotting factors, along with proteins.28
Fresh frozen plasma is often used in children, and albumin or synthetic
high molecular weight starches are used in adults. 18
Licensed indications for human albumin solutions are emergency
resuscitation of shock, acute management of burns and conditions associated
with hypoproteinemia. As human albumin has limited availability and high
cost, its use should be restricted to proven indications. 31
Fresh frozen plasma is probably the best colloid solution for acute burns
resuscitation, particularly when there is a risk of coagulopathy. However, the
main drawback is that it carries the risk of transmission of infection. 24 Plasma
transfusions are a rational treatment for restoring protein level due to the fluid
shift. 26
14
One of the thresholds for plasma transfusion is the presence of active
bleeding from wounds.23 Fresh Frozen Plasma continues to be used as
prophylaxis, before surgery or invasive procedures, even in the absence of
clinical bleeding. But the effectiveness of FFP remains unanswered.32
Colloids – Beneficial or Detrimental?
Colloid based resuscitation was excluded from Baxter’s original
Parkland formula by National institutes of Health (NIH) consensus.33, 34 The
advantages of protein based colloids in burns resuscitation are reduced tissue
edema in both burnt and non-burnt tissues, which reduce the incidence of
compartment syndrome and fasciotomy, and lesser chance of ileus.
Disadvantages include higher costs of albumin; anaphylaxis with dextrans,
acute renal injury with Hydroxyethyl Starch (HES); possible anaphylaxis,
Transfusion-transmitted Infections (TTI) and Febrile Non hemolytic
transfusion reaction (FNHTR) with Fresh Frozen Plasma.24,28,35,36
The higher risk of mortality among burns patients receiving colloids
could possibly be attributed to the fact that patients included in the studies were
often more critically injured and their mortality can only be ascribed to a
combination of multiple factors and co-morbidities rather than colloids. Recent
reports, while refuting the assumption that resuscitation with colloids in burns
patients is harmful, give differing data to say that colloids improve
survival.24,37,38
15
Albumin might increase the risk of death in patients with hypovolemia,
burns and hypoproteinemia. The reason for this increased mortality with
albumin is that albumin is believed to have anticoagulant properties, inhibiting
platelet aggregation and enhancing the inhibition of factor Xa by Anti-
Thrombin III. Furthermore, albumin can distribute across capillary membrane
and this increased leakage into the extravascular space reduces oncotic pressure
difference, making edema more likely.31
With advanced and scrupulous screening of blood components, fresh
frozen plasma can be more beneficial than detrimental, for burn resuscitation.28
Burns and Transfusion:
Blood transfusion has become ubiquitous in treating major burn injury
(> 20% TBSA burn), 39 as red blood cell (RBC) transfusion is one of the few
treatments that adequately restore tissue oxygenation especially when oxygen
demand exceeds supply.40
Improvement in donor blood screening procedures and implementation
of stringent quality measures has improved the safety of allogeneic transfusion,
especially in more developed countries.40
Duration of hospitalization was prolonged in burns patients who were
transfused with allogeneic blood components and with advancing age. Fresh
plasma is necessary in low plasma protein levels while red cells are necessary
for oxygen delivery to injured sites.41
16
Burns patients, not receiving blood transfusions, had fewer
complications than patients receiving transfusion due to the fact that those not
receiving transfusion have smaller burn injury and less inhalation injury.
Survivors required fewer escharatomies and fasciotomies.39
It has been estimated that 117 ml of blood volume is lost for every 1%
of body surface area excised and grafted.42 While total red cell transfusions
were associated with % TBSA, Acute physiology and chronic health evaluation
(APACHE II) score and number of surgical interventions, transfusions
specifically related to the anemia of critical illness were associated with the
initial APACHE II score.5
The specific level of hemoglobin or hematocrit, which dictates when to
transfuse red cells is known as the ‘Trigger’. But there is no one ‘common
trigger’ with values ranging from 6 gm% to 8 gm% in different centers.42
Historically, the transfusion threshold for RBCs was hemoglobin below
10.0 gm/dL or hematocrit below 30%, which was first proposed by Adams and
Lundy. After 1988, when the National Institutes of Health consensus
conference in the United States did not find evidence to support a single
criterion for transfusion, several guidelines were published, recommending a
range of hemoglobin values between 6.0 to 10.0 gm/dL.40
Numerous trials have shown that a restricted blood transfusion protocol
(to maintain a hemoglobin of 7-9 gm %) has a lower mortality, cardiac
complication and organ dysfunction compared with liberal transfusion (to
maintain Hb of 10-12 gm %).42
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Despite modifications to transfusion thresholds over the past 20 years,
transfusion thresholds still differ between various burns centers.5 In patients
without cardiac compromise, blood transfusion can be withheld to hemoglobin
levels as low as 7.0 to 8.0 gm/dL as long as there is no active bleeding. 40 Blood
transfusions are necessary in burn patients losing more than 700 ml at any one
time or have a fall in Hemoglobin to 8 gm%.41
There is neither an optimal transfusion protocol nor a discrete
transfusion trigger. An important consideration for blood transfusion is acute
blood loss with the signs of hemodynamic stability. Bedside clinical signs like
blood pressure, heart rate, fall in urine output and change in mental status have
been proven to be insensitive and nonspecific. Coagulopathy can be prevented
by preventing hypothermia, timely use of fresh frozen plasma and correcting
acidosis. 42
Younger patients and less ill patients were harmed by Red cell
transfusion while older and more ill patients benefited. The benefit of
conservative strategy was greater among younger patients and those with the
APACHE II score <20. Thus, Universal transfusion protocols may be harmful,
but RBC transfusion should not be viewed as uniformly hazardous.3
Complications can prevent early wound healing. Delayed wound healing
leads to prolonged hospital length of stay.43
Age of red blood cell storage and clinical outcomes:
Red blood cells are stored upto a maximum of 42 days after donation
and the storage lesions in red blood cells after prolonged storage is a well
18
proven fact. But there is uncertainty on the clinical consequences of fresher or
older red blood cell units stored for different durations before transfusion. The
clinical outcomes of interest were death, length of hospital stay, incidence of
infections and body functional assessment. Ville Pettila et al.44 for the
Australian and New Zealand Intensive Care Society (ANZICS) group have
found that older red blood cells are associated with increased mortality in
critically ill patients. But other studies from AABB technical manual and
Cochrane review failed to find a conclusion that clinical outcomes differed
with different durations of storage.45, 46, 47
Appropriateness of Red blood cells Transfusion:
The appropriateness to transfuse blood include not only the pre-
transfusion hemoglobin levels, but also events like ongoing blood loss followed
by symptoms and signs in the patient like changes in blood pressure and heart
rate. Post-transfusion hemoglobin and documentation of informed consent for
transfusion also signify appropriateness.2
A loss of less than 15% of blood volume does not require blood
transfusion unless there is pre-existing anemia. Patients with Hb concentrations
below 6 gm/dL almost always require red cell transfusion. In those with Hb
between 6 and 10 gm/dL, the decision to transfuse is based on clinical status
evaluation. Patients with Hb values above 10 gm/dL rarely require transfusion.
Another guideline gives a trigger of ? 8 gm% in burns patients who are not
critically ill and without cardiopulmonary compromise.48,49,50 However,
decision is made taking other factors into consideration: type of surgery, extent
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of blood loss, presence of adverse clinical conditions (age of patient,
cardiopulmonary compromise).48,49,51,52,53
Among patients in intensive care, restrictive transfusion threshold with
Hb values between 7-8 gm/dL does not increase mortality, morbidity or
duration of hospitalization. Exceptions to restrictive threshold include patients
with cardiovascular disease.51
Inappropriate uses of Red blood cell transfusion include a) Anemia with
Hb above 10 gm/dL, b) to expand the circulatory volume, c) to replace
hematinics and d) to accelerate wound healing.51
Monitoring indices for clinical auditing include use of red cell
transfusion in anemia with Hb > 10 gm/dL and to expand circulatory volume.51
Various studies show the appropriateness of RBC transfusions varying from
97% to 54.1%. 3,54,55
Appropriateness of Plasma Transfusion:
If plasma unit is prepared from the unit of collected whole blood and
frozen within eight hours from donation, the unit is termed fresh frozen plasma
(FFP).56 The typical adult dose of plasma is 10 ml -15 ml per kilogram of body
weight.57
According to the Transfusion Medicine Advisory Group (TMAG) of
British Columbia, inappropriate uses of Fresh Frozen Plasma include use in
hypovolemia (intravascular volume expander), to enhance or promote wound
healing, as a nutritional support, protein losing states or in Burns.57
20
Inappropriate indications for Fresh Frozen Plasma include expansion of
circulatory volume, hypoproteinemia and for nutritional purposes.51 Other
inappropriate use is insufficient volume transfused.56
Monitoring indices for clinical auditing are; a) use of FFP in situations
like expansion of circulatory volume, hypoproteinemia and for nutritional
purposes and b) evaluating the appropriateness of the dose of FFP.51 Various
studies show inappropriate FFP transfusions ranging from 22.7% to 52%.56,58,59
Appropriateness of Platelet transfusions:
The current recommendations for platelet transfusion is 10,000
platelets/?L in clinically stable patients.51 The surgical patient with active
bleeding usually requires platelet transfusion if the count is < 50,000/?L. 51, 60
Monitoring indices for clinical auditing include prophylaxis at a
transfusion threshold, which was higher than recommended.51
Burns Treatment Centres:
A burns center must be well equipped and requires the collaboration of
various specialties including plastic and reconstructive surgeons, infectious
disease specialists, anesthetists, dieticians, psychologists, pediatricians,
physiotherapists, microbiologists and epidemiologists. The importance of
nursing needs no special mention. 10
21
Cause of Burns:
Burn injuries are a major public health problem due to its high mortality,
morbidity and disability among young and middle aged adults. It may be
accidental, suicidal or homicidal.61 Flame was the most common cause of burn
injury followed by scald, electrical and chemical burns. Burns was more
common in females. Every 1% increase in TBSA is significantly associated
with a 6% increase in risk of mortality.61,62
Age of the burns patient:
Advanced age is a risk factor for late post-burns unfavorable
outcomes.10 Advancing age poses significant challenges after burns, as elderly
patients have increased risk of mortality and on average require two times the
length of hospitalization.63
Body temperature in Burns patients:
A crucial point that is overlooked in burns is maintaining body
temperature. Hypothermia contributes to coagulation or platelet dysfunction
and increases the need to transfuse blood components. Measures like
maintaining a higher ambient temperature, covering of exposed skin, using
warm blankets or radiant heaters help to effectively maintain core temperature
of the burns patient.42
Burns and electrolytes:
Changes in capillary permeability have been demonstrated in both
burned and unburned tissues contributing to leakage of intravascular
22
components into the extravascular space. Cellular membrane permeability
leads to intracellular sodium accumulation and consequent cell swelling. 28
Disruption of transmembrane sodium–ATPase activity presumably leads to rise
in intracellular sodium which contributes to hypovolemia and cellular edema. 27
Burns and platelet levels:
Thrombocytopenia is present in most burns wound infections in addition
to fever (temperature > 38.40 C) and leukocytosis (white blood cell count >
10,000 cells/cu. mm).6 Free radicals released by acute burns result in oxidation
of proteins (oxidatively modified proteins) of which oxidized albumin
increases aggregation of erythrocytes and platelets.64
Declining platelet count occurs very early in septicemia even before
clinical signs and symptoms develop. Thus thrombocytopenia can be an early
indication of bacteremia in burns patients. Rebound rise in platelet count on
subsequent post-burns days occurred in burns survivors and the platelet count
was not dependent on the extent of burn injury. So, serial platelet count in post-
burns period can be a prognostic indicator in burns patients.65
Metabolism in Burns:
Metabolic response to burns injury has two phases: initial ebb stage,
where there is a deficit in plasma volume and insulin levels, shock,
hypothermia and decreased overall metabolic rate. This is followed by a flow
stage, characterized by a rise in catabolic hormone concentration, resulting in
tachycardia, fever, proteolysis, gluconeogenesis and increased overall
metabolic rate.66
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Hypermetabolism begins at about fifth post-burns day and can persist
for an year leading to loss of lean body mass and reduced bone mineral density.
Metabolic response in patients with more than 40% TBSA is 100% above
resting metabolic rate.66 In general, 10% loss of total body mass leads to
immune dysfunction; 20%, to decreased wound healing; 30%, to severe
infections; and 40%, to death.67
Early nutritional support is a critical component of management of
injured patients, to prevent ileus, stress ulcers and effects of hypermetabolism.
They also had a shorter stay in the Intensive Care Unit and lower wound
infection rates.68
Patients who have severe burns, have active catabolism and high levels
of energy consumption that can result in progressive weight loss, immune
dysfunction, visceral organ dysfunction, delayed wound healing or even death.
Adequate and rational nutrition helps to ameliorate nutritional status, reduce
complications and thus improve prognosis of burns patients. While
underfeeding leads to catabolic complications with poor prognosis, overfeeding
increases metabolic burden and aggravates organ dysfunction.69
Even though many formulae exist for estimating energy needs of burns
patients like Pennisi, Toronto, Schofield, Harris-Benedict and American
Society for Parenteral and Enteral Nutrition (ASPEN) recommendations, the
simple formula used is the Curreri formula. Harris-Benedict formula is most
widely used in children.66
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Diet consisted of high protein with balanced carbohydrate and fat diet
and energy requirement was calculated as per Curreri formula:7
Age 16-59 years: (25) W + (40) TBSA
Age ? 60 years: (20) W + (65) TBSA
In the Curreri formula, energy estimate for every 1% TBSA is 40 Kcal
which is higher than actual consumptions of burns patients. The Milner formula
is the most accurate energy estimation formula currently in use clinically and it
takes into account the three core factors that affect energy consumption: %
TBSA, Post burn day (PBD) and Body surface area (BSA). But formulas can
only give a rough range and cannot estimate the actual energy consumptions in
patients.69
Early enteral nutrition (within 24 hours) of about 30 Kcal/kg/day
reduces caloric deficit while 2 g/kg/day of protein intake (15 – 20% of total
caloric intake) is required by all critically ill patients in 24 hours.66
Burns and serum glucose levels:
Insulin is not just a glucose controlling molecule, but also a therapeutic
agent which improves muscle protein synthesis, skin protein synthesis and
thereby wound healing, positively balanced energy efficiency and a massive
impact on inflammatory and acute phase responses.70
The 10- to 20- fold rise in corticosteroid and catecholamine levels thwart
insulin action and cause increased lipolysis, proteolysis, gluconeogenesis and
energy consumption. This state can last up to 12 months post-burns. Plasma
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glucose and insulin levels remain high during hospital stay. This excessively
high glucose levels can result in poor morbidity and mortality outcomes.7, 67 An
increase in hepatic gluconeogenesis coupled with insulin resistance results in
hyperglycemia.66
It is a proven fact that hypoglycemia is associated with increased
mortality and morbidity in the critically ill. A glucose range of 90 to 140 mg/dl
is ideal for treating burns patients.70 Insulin, in doses to maintain blood glucose
around 120 mg/dL, decreased pro-inflammatory cytokines and increasing anti-
inflammatory cytokines due to direct binding of insulin on signal transcription
factors.71
Carbohydrates provide fuel for wound healing and also have a protein
sparing effect. The minimum baseline adult requirement of carbohydrates is 2
g/kg/day, but the maximum rate of assimilation of glucose is 7 g/kg/day in the
severely burned. This is due to the fact that although glucose delivery to
peripheral tissues increases by up to 3 fold, glucose oxidation is restricted,
leading to elevated fasting glucose.67
Burns and serum proteins:
The normal level of albumin is 35 – 45 g/L. Albumin loss in acute burns
result from protein exudation through burns wound and decreased synthesis in
liver, leading to a fall to about 80% of normal albumin and prealbumin levels.
Loss of albumin through burns wound is greatest in the first 3 post-burn days,
after which they stabilize.64 Albumin levels in plasma showed a permanent
decline which was more pronounced in the fourth and fifth week of hospital
treatment.72
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Soon after burns, there is an increase in metabolic rate leading to protein
degradation, muscle wasting and loss of lean body mass. Patients with serum
albumin levels at a cutoff point of 21 g/L have a 30% increased risk of 30 day
mortality and up to 65% risk of 30 day morbidity.67
Partial thickness burns usually blister and protection against fluid loss is
lost. A patient’s entire amount of serum proteins accumulates in burns wound
fluid approximately within 24 hours after a 20% TBSA injury. 30
Serum albumin levels are inversely related to risk of death for both acute
and chronic illness in patients. For each 2.5 g/L fall in serum albumin level, the
risk of death increases by about 24% to 56%. 31 Hypoalbuminemia is also
associated with prolonged length of stay in Intensive Care. But Albumin level
is not a sensitive indicator of protein nutrition state as it has a long half-life of
about 20 days. Still it is a reliable indicator of morbidity and mortality in burns
patients.64
Burns and electrolytes:
Risk factors for serum sodium dysregulation are unconsciousness,
parenteral feeding, age and renal insufficiency. In critically ill patients,
hypernatremia is associated with adverse outcome. Serum sodium
concentration can be used to calculate need of fluid resuscitation during
maintenance phase. 30
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Burns and renal parameters:
Patients with better prognosis did not develop acute renal failure and had
initial creatinine level less than 1.7 mg/dL.73 Early changes in renal function
can predict inflammatory response and hypoperfusion, which results in
mortality.74
Leukocyte count in Burns:
Total Leukocyte Count was significantly higher in non-survivors than in
survivors at the time of admission but not subsequently. The signs of adverse
outcomes were: rise in total leukocyte count by 20% or > 16000 or <
4000.Higher total leukocyte count during hospitalization correlated with
infection or sepsis.7 The inflammatory response after burns is short lived and
lasts only a few days, hence the importance of leukocyte level on admission.75
Scoring systems in Burns:
A scoring system enables plot of performance over time and becomes a
standardized tool which allows for improved research and comparison of
therapeutic interventions. A good scoring system can help to provide bedside
prognosis, provision of treatment services and to triage patients.74
The various prognostic systems are Abbreviated Burn Severity Index
(ABSI), Cape Town modified burns score, Ryan score, Burd score, Belgian
Outcome in Burn Injury score and laboratory based prognostic scoring which
have their own advantages and disadvantages. Although Non Burn specific
scoring measures like Acute Physiology and Chronic Health Evaluation
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(APACHE) score, Sepsis-related Organ Failure Assessment (SOFA),
Simplified Acute Physiology Score (SAPS), Pediatric Risk of Mortality
(PRISM) prove their validity in a general Intensive Care Unit and are also
helpful as reliable predictors of mortality in burns patients, none of these scores
take into account the profound physiological effect of burns itself.
The simple models like APACHE II are still relevant in developing
countries like India and shows good discriminating ability between survivors
and non-survivors.76 APACHE II score also has better sensitivity and
specificity than clinical evaluation in mixed Intensive Care population.74
Burns and Liver:
Liver damage in burns injury results from hypovolemia-related
hypoperfusion in the early phase; and sepsis, drug toxicity or blood transfusion
in the later phases. Patients with a diagnosis of liver disease were significantly
more likely than all other patients to die and required significantly longer
lengths of both intensive care and total stay.77
Alteration of liver function tests is extremely common following major
burns with transient elevation of the aspartate aminotransferase, alanine
aminotransferase, and particularly the alkaline phosphatase in 50% of cases.
They are usually benign and resolve spontaneously. Elevation of the serum
bilirubin is somewhat less common but of more serious consequence. Patients,
who show severe and persistent derangements of the liver enzymes, including
elevated bilirubin, usually have some associated complication of their burns,
such as burns wound sepsis.77
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Clearance of bacteria by Kupffer cells of the liver normally prevents
gut-derived bacteria from entering the systemic circulation. There is a loss of
physical barrier function in the gastrointestinal tract after burns injury, which
allows translocation of bacteria and endotoxin to the portal circulation, which
can lead to multiple-organ failure. The loss of the liver’s ability to clear gut-
derived bacteria most likely increases the risk of post burns sepsis in burnt
patients.77
After major burns, hepatic protein synthesis shifts from constitutive
proteins like albumin and prealbumin to acute phase proteins, which participate
in inflammation and wound healing.77
Burns and Nutrition:
The ability of burns patient to handle glucose is limited to 5 mg/kg/day,
i.e. for an adult 500 gm or 2000 Kcal/day. High protein intake up to 1.5 gm - 3
gm/kg/day or 20-25% of total energy is the maximum required for burns
patients. Fat should constitute no more than 25-30%. Vitamins and minerals
should be supplemented. Anorexia and aversion to food are the major factors
which hinder intake of calories and proteins. There was no difference in
outcome with vegetarian and non-vegetarian diet on clinical outcome.78
Burns and Enteral Nutrition:
Even though enteral resuscitation is unreliable and impractical, when
gastrointestinal tract is intact and access to medical care is limited, oral
resuscitation can be effectively initiated with balanced salt solutions. Oral
resuscitation is also appropriate in awake and alert patients with burns < 20%,
as the risk of systemic inflammation is low. 27
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Optimal nutrition for the burns patient is best accomplished by early
(within 24 hours after injury) initiation of enteral nutrition which modulates the
hypermetabolic response by decreasing the circulating levels of
catecholamines, cortisol and glucagon.67 This also led to better nutritional and
metabolic parameters, lower body mass index changes, less inflammatory
response, lower infection and mortality rates.72
Burns and Anemia:
Red blood cells are lost through heat induced damage while Burn injury
and fluid resuscitation, in combination, results in anemia and thrombocytopenia
during the acute phase. Red cells are also lost through bleeding burns wound,
particularly during wound excision and are closely related to burnt surface
excised.9
The anemia of critical illness is caused by combination of decreased
erythropoiesis stemming from decreased erythropoietin production and
response, bone marrow dysfunction and poor nutrition; and persistent blood
losses due to surgical management of wounds and blood sampling. This anemia
occurs usually after 7 days or 21 days in intensive care units. Burns patients
suffer, from acute blood losses by the burns injury and subsequent anemia of
critical illness, which necessitates blood transfusions for correction.5
Hemoglobin value is still the major determinant of the decision to
transfuse. During admission, almost 30% of patients had admitting hemoglobin
of less than 10 gm/dL. Almost 50% of these patients had neither a history of
anemia nor of acute bleeding.79 Anemia was a strong predictor for ICU
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admission and blood transfusion within the first 24 hours. Anemia at the time
of admission was associated with age of patient, injury severity and female
gender.80  95% of patients admitted in Intensive Care Unit have abnormally low
hemoglobin levels by ICU day 3.3
There was no difference of hemoglobin levels between vegetarian and
non-vegetarian diet in burns patients. Iron absorption is aided by high vitamin
C content in vegetarian diet.78
Complications of Blood transfusion in Burns:
Complications of blood transfusion in burns patients include spread of
Transfusion Transmitted Infections (TTI), Transfusion Related Immuno
Modulation (TRIM), Transfusion Related Acute Lung Injury (TRALI) and
Hemolytic Transfusion Reactions (HTR) among others.42
Allogeneic blood transfusion is associated with immunomodulation
which includes decreased immune cell proliferation with decreased T cell
mediated immunity and thus a predictor of minor wound healing
disturbances.41,80
In trauma patients, blood transfusion is an independent risk factor for
death, perioperative infection, multiple organ failure and admission to Intensive
Care Unit. It has been well documented that blood transfusion within 24 hours
of admission was an independent predictor of mortality and ICU length of
stay.80
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The harm from RBC transfusion has been attributed to ageing of blood
and loss of function due to storage lesion which leads to worsening
microcirculation and nitric oxide bioavailability.3 Packed red cells stored for a
long time before transfusion results in poorer oxygen delivery. 41 The number of
red cell units older than 14 days and number of units older than 21 days were
independent risk factors for multi organ failure, when they were transfused to
patients within the first 6 hours of trauma.80
The worse outcome in patients who were transfused blood within the
first 24 hours of trauma can have the following explanations: Blood transfusion
increases the risk of adverse outcome or patients who require blood transfusion
have more severe illness and blood transfusion is simply a marker of increased
severity.80
The development of storage lesions in red cells over time may be
responsible for the possible adverse effects of RBC transfusion. The
biochemical changes that occur during storage are: a reduction in 2,3-
diphospho glycerate, alterations in pH, hypocalcemia, changes in nitric oxide
levels, cell lysis and release of free hemoglobin along with increase in
cytokines. These changes can increase red cell membrane fragility,
compromising microcirculatory flow and inflammatory cytokine release which
explain the unfavorable outcomes in critically ill patients. Exposure to even a
single unit of older red cells can lead to unfavorable outcome in the critically
ill, independent of the volume of transfused red cells.39
Evidence suggests that restrictive transfusion while reducing the risk of
exposure to RBC transfusion and the total number of units transfused; do not
adversely affect function or length of stay. In countries where there is
inadequate testing for viral TTIs, it is better to avoid transfusion.40
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Transfusion Related Immuno Modulation:
Antibiotics cannot eliminate infections without a concomitant adequate
host response. An appropriate antibiotic administered for infected burns will
not prevent death, even if the organism in the inoculum is highly sensitive in
vitro because of depression of host defense mechanism.81
The burned patient shows several defects in immune defense mechanism
which include: a defect in initial antigen processing, selective increase in IgG
catabolism, profound depression of central cell mediated immunity and a
suppression of lymphocyte response which enhances skin graft survival. 81
Blood transfusion complicates the scenario and is an independent
predictor of ICU admission, systemic inflammatory response syndrome and
hospital length of stay independent of injury severity.39 Of the deleterious
effects of red cell transfusion, the most likely factor to mortality in critically ill
is related to immunomodulation rather than allergic reaction or infectious
transmission.79
Patients who received non-leukofiltered allogeneic blood transfusion
experienced postoperative bacterial infections and prolonged length of stay in
hospital. The changes in cytokine patterns contribute to increased morbidity in
patients receiving even one-time blood transfusion due to
immunomodulation.82
Even though site of infection was not a risk factor, number of infective
episodes correlated with number of blood transfusions with the risk increasing
by 13% per unit of blood transfused.39 Transfusion associated
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Immunomodulation is a recognized cause of increased length of
hospitalization, antibiotic usage and financial burden in allogeneically
transfused patients.82
Fresh frozen plasma contains 0.025 gm of albumin/mL and fibronectin
which makes it advantageous in early fluid management in burn injury.83, 84 But
even FFP transfusions are also associated with TRIM and its complications,
like increased susceptibility to infections and prolonged hospital stay in the
critically ill patients.85
Burns and Length of stay in hospital:
The true cost of burn injuries, in addition to the monetary cost, includes
pain suffered by the patient, work hours lost due to hospital admission,
emotional impact on family and friends of the patient, which is impossible to
completely measure.86
With continued improvement in all aspects of management of burns
patients, mortality rates have shown marked improvement and as a result,
usefulness of mortality rates as a measure of quality of care and burn service is
being questioned. Quality of life and functional status are instead being
examined as parameters of burn care, of which hospital length of stay data are
easy to collect and measure across different services. They provide an indirect
indication of morbidity and clinical complications, as well as cost of care.87
The rule of thumb is that length of stay (LOS) in days is roughly equal
to value for Total Body Surface Burns.74  The mean LOS per %TBSA is about
2 days for 20% to 60% burn injury. In patients with burns less than 20% TBSA
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the mean LOS per %TBSA is 1.5 days, while in those with more than 60%
TBSA, mean LOS per %TBSA rises to 3 days.75, 86
Factors contributing to prolonged length of stay in hospital are a delay in
hospitalization, deconditioning, social and discharge issues.63 The gender of the
patient was more predictive of length of stay than age.74 Inhalation injury
prolongs the hospital length of stay by three folds. 20 Flame burns require longer
hospital stays than electrical and scald burns.10 Depth of burns was not
significantly associated with hospital length of stay. 88 Restricted use of RBC
transfusion was not associated with a prolonged length of hospital stay.40
The LOS for less severe burns can be paradoxically prolonged because
of confounding factors like comorbidities and social circumstances.87
Burns and Collagen dressing:
An ideal dressing material for burn wounds has to maintain a moist
environment, act as a medium for gaseous exchange while acting as a barrier to
bacteria and toxic contaminants. Bovine collagen dressing fulfills this necessity
in Burns as it is hemostatic, has low antigenicity and provides mechanical
support while forming an essential substrate for cell adhesion and migration. 89
The advantages of collagen dressing are: ease of availability in various
sizes, ease of removal, ability to remain stable at room temperatures for 3 years
and cost effective. Only disadvantage is that if placed on flexor surface, it can
crack when dry and wound becomes visible. 89
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Burns and Surgical Procedures:
It is estimated that 5% of blood volume is lost for every 1% of TBSA
excised and grafted. This high blood loss is because diffuse bleeding indicates
that the wound bed is viable and is used as endpoint for excision. 90 Early
wound excision (within 24 hours after injury) minimizes blood loss, especially
in large burns (> 30% burns), because hyperemia has not occurred.42
Escharotomy is the division of burn eschar. A circumferential deep
dermal or full thickness burn is inelastic and on an extremity will not stretch.
Fluid resuscitation leads to the development of burn wound oedema and
swelling of the tissue beneath this inelastic burnt tissue. Thus tissue pressures
rise which can impair peripheral circulation. Circumferential chest burns can
also cause problems by limiting chest expansion and impairing ventilation.
Both of these situations require escharotomy. Only the burnt tissue is divided,
not any underlying fascia, differentiating this procedure from a fasciotomy. 18
Surgery inevitably causes tissue damage resulting in a cytokine
mediated inflammatory response via humoral system. Other effects include
hypersecretion of catecholamines and pituitary hormones resulting in increased
cardiovascular stress and impaired wound healing. These hormonal imbalances
also results in a catabolic state.88
Early burn wound excision within the first few days of burns has
improved survival by reducing risk of systemic inflammatory response
syndrome from dead tissue and attenuating the hypermetabolic response by
preventing protein loss and sepsis.90 It also shortens period of wound
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inflammation, thus reducing hypertrophic scarring. No more than 20% of
burned area is excised during any single procedure.6
While large TBSA burn injury patients benefit from surgery, smaller
burn injuries rest on a balance between risks and benefits. Benefits include
early healing, reduced infections and better scar quality while risks include
fatigue, sleep disturbances, hyperthermia, immunosuppression and possible
need for blood products.88
A major emphasis is placed on blood conservation techniques in
surgery/ excision which minimize blood transfusion needs, without sacrificing
efficacy of procedures. 90,91
Burns and sepsis:
There is interplay of pro-inflammatory and anti-inflammatory cytokines
resulting in a predominantly anti-inflammatory state, in an effort to restore
normal physiology. Complement levels rise to supranormal levels which can
cause end organ damage and this is complicated by increased levels of C3b
which is immunosuppressive. All the derangements result in increased
exposure to pathogens while the immune system is unable to eradicate
infections.6
Immediate colonization of burn wounds occurs with patient’s normal
skin flora viz. Staphylococcus aureus and Streptococcus pyogenes which are
located deep within sweat glands, within first 48 hours. Subsequent
colonization by gram negative flora derived from patient’s own gut or
respiratory flora or from hospital environment complicates the picture after 5 to
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7 days. Pseudomonas aeruginosa is the most common cause of burn wound
infection in many centers.  Preventing wound infections can result in better
outcomes in burns patients with quicker recovery from hospital, as infection
preceded multiple organ dysfunction syndrome in most burns patients.6, 12
Multiple blood transfusions are associated with risk of
Immunosuppression and increased risk of nosocomial infections and hence,
reducing transfusions can help benefit patient care. 5, 90 Transfused patients
showed relationship between the number of units transfused and risk for
nosocomial infections, which rose by a factor of 1.5 for every unit of blood
transfused.80 Risk of infections was 19% higher in patients receiving liberal red
cell transfusion.40
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MATERIALS AND METHODS
Study design:
Prospective Study
Study Population:
Patients admitted and treated in the Burns ward/ Burns Intensive Care
unit of Kilpauk Medical College.
Study area:
? Burns ward, Kilpauk Medical College
? Department of Transfusion Medicine, Kilpauk Medical College
? Department of Transfusion Medicine, The Tamilnadu Dr. M.G.R.
Medical University, Chennai
Sample size and Study Period:
Burns patients admitted and treated between September 2014 and
August 2015, who fulfill inclusion criteria (Purposive sampling) were included
in this study.
Inclusion criteria:
? Burns patients (age more than 16 years) #
? Burn size (15 – 40 % TBSA) *
? This study included only Burns Patients who had survived
treatment.
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 # (APACHE II score calculation has not been validated in age < 16
years)74
   * (< 15% TBSA Hospitalization is not necessary 8
        > 40% Mortality Risk Increases) 20, 28
Exclusion criteria:
Burns patients
? < 16 years.
? Burn size [<15 % & > 40 % TBSA].
? Previously treated and admitted later for reconstructive surgeries.
? Not willing to participate in the study.
Informed consent:
Informed consent from patients/ patients’ relatives was obtained for
willingness to participate in this study.
Operational Definition
I.  Appropriate Use of  Blood Components in Burns Patients
To study the appropriate use of blood and blood components in burns
patients following guidelines were used.
1. Red Blood Cells
New York State Council on Human Blood and Transfusion Services
Guidelines for Transfusion of Red Blood Cells - for Burns Patients.48
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The following criteria are recommended for RBC transfusion of stable
burn  patients without active bleeding:
a. For patients not critically ill and without cardiopulmonary
compromise, RBCs may be transfused for hemoglobin of ? 8
g/dL.
b. For critically ill patients and/or those with cardiopulmonary
compromise, RBCs may be transfused for hemoglobin of ? 10
g/dL.
2. Fresh Frozen Plasma
Baxter’s original Parkland formula93
a. Initial 24 hours: Ringer’s lactate (RL) solution 4 ml/kg/% burn for
adults and 3 ml/kg/% burn for children.
   This formula recommends no colloid in the initial 24 hours.
b. Next 24 hours: Fresh frozen plasma given as 20–60% of calculated
plasma volume (0.5 ml/kg/%TBSA). No crystalloids. Glucose in
water is added in amounts required to maintain a urinary output of
0.5–1 ml/hour in adults and 1 ml/hour in children.
If FFP was given in inadequate doses, it was considered inappropriate
transfusions. Transfusion of FFP in the initial 24 hours of burn injury was also
considered inappropriate.
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3. Platelet concentrates
a. Thrombocytopenia in Burns patients.91
i. Thrombocytopenia requiring platelet transfusions is rare in
burns patients.
ii. Burns patients with thrombocytopenia can be managed
similarly to any other critically ill patient with sepsis.
iii. Although platelet transfusions are not common in burns
patients, it is necessary to limit its use
b. Platelet transfusion thresholds (AABB): 45
Table 2: Platelet transfusion thresholds according to AABB:
Indications Threshold Platelet
count (in cells/?L)
All patients 10,000
Patients with fever or recent hemorrhage 20,000
Patients with coagulopathy, on heparin,
or with anatomic lesion likely to bleed
20,000
Surgical patient with active bleeding 50,000
Intracerebral, pulmonary or ophthalmic
hemorrhage
1,00,000
43
II. Length of stay (LOS) for Wound Healing
1. Age
2. TBSA
3. APACHE II Score (Table 3)
4. Blood Component Transfusion
i. Total number of Components transfused and LOS
ii. Storage age of red cells and LOS
iii. Transfusion of FFP and LOS
iv. Influence of transfusion on wound infection
5. Surgical Procedures
Delayed wound healing leads to prolonged length of hospital stay 43 and
in this study length of hospital stay was taken as the measurable variable.
The age of RBC unit was determined by subtracting the date of
collection from the date of transfusion.44
Statistical analysis:
Data entry and analysis were done using SPSS software version 21.0.
Statistical analysis were done using chi square test (?2) and analysis of variance
for categorical variables and Pearson correlation (r) to find correlation. P < 0.05
was considered significant.
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Table 3: APACHE II score calculation chart 94
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Table 4: APACHE II score and risk of mortality
APACHE II
score Approximate Mortality Interpretation
0 - 4 4%  non-operated 1% post-operative
5 - 9 8%  non-operated 3% post-operative
10 - 14 15%  non-operated 7% post-operative
15 - 19 24%  non-operated 12% post-operative
20 - 24 40%  non-operated 30% post-operative
25 - 29 55%  non-operated 35% post-operative
30 - 34 73%  non-operated 73% post-operative
35 - 100 85%  non-operated 88% post-operative
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RESULTS
I. APPROPRIATENESS OF BLOOD AND COMPONENT
TRANSFUSION IN BURNS PATIENTS
1. Total blood components utilized in Burns patients:
Whole blood PRBCs Platelets FFP Cryoppt
Bl comp 223 85 1 441 0
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Fig 3: Total blood components utilized in burns patients
(PRBC – Packed red blood cells, FFP – Fresh frozen plasma, Cryoppt –
Cryoprecipitate)
In this study population (n = 122), fresh frozen plasma was the
commonly used blood component.
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2. Distribution of Blood components transfused in Burns patients:
Whole
blood PRBC FFP
Platel
ets
WB +
PRBC
WB +
FFP
PRBC
+ FFP
WB+P
RBC +
FFP
WB +
PRBC
+ FFP
+ Plt
No
transf
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Component 2 1 36 0 2 42 9 28 1 1
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Fig 4: No. of patients for whom various blood components were used in
combination
(WB – Whole blood, PRBC – Packed red blood cells, FFP – Fresh frozen
plasma, Plt – Platelet concentrate)
In this study population (n = 122), Whole blood with fresh frozen
plasma was the commonly used combination of blood components in burns
patients.
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3. Blood transfusion statistics in Burns patients:
Table 5: Mean and Standard deviation of various blood components used:
Component
Minimum
(in
number
of units)
Maximum
(in number
of units)
Mean (in
number of
units)
Std.
Deviation
All components
(whole blood, PRBC,
FFP & PC
(n = 121 patients)
1 33 5.75 4.80
Total red blood cells
(Whole blood and
PRBC)
(n = 85 patients)
1 25 3.41 3.19
Whole blood
(n = 76 patients)
1 17 2.93 2.39
Packed red cells
(n = 41 patients)
1 8 2.08 1.46
Fresh frozen plasma
(n = 114 patients)
1 11 3.61 2.51
Platelets Concentrate
(n = 1)
0 1 - -
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4. Age of red cells transfused in Burns patients:
0-7 days 8-14 days
15-21
days
22-28
days
29-35
days
36-42
days
Age of RBC 65 94 73 49 24 3
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Fig 5: Storage age of RBCs utilized in patients, divided in weeks
 In this study population (n = 122), most red blood cell transfusions
(whole blood and packed red blood cells) belonged to second and third week
of storage (n = 167).
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5. Appropriateness of red cell transfusion:
i) Appropriate Red blood cell transfusions based on Hemoglobin
trigger:
64%
36%
Transfusions with hemoglobin trigger of 10
gm/dL
< 10 gm% (n = 198)
> 10 gm% (n = 110)
Fig 6: Appropriate transfusions with transfusion trigger of 10 gm/dL
In this study population (n = 122), when a hemoglobin trigger of 10
gm/dL was applied, 64% of all red blood cell transfusions (n = 198) can be
considered appropriate transfusions.
The reasons for inappropriate transfusions were:
i) Transfusion when hemoglobin level was > 10 gm/dL
ii) To promote wound healing
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ii) Comparison between whole blood and packed red blood cells:
Table 6: Difference in mean LOS between patients transfused with whole
blood and PRBC:
Variable
Red blood cell
transfusion
Length of stay (in days)
Mean (Std. Deviation)
P value
Patients transfused with
only whole blood
(n = 44/122)
22.70 (12.06)
> 0.05
Patients transfused with
only PRBC
(n = 9/122)
21.67 (5.21)
In this study population, there was no significant difference in mean
length of stay between burns patients transfused with only whole blood and
those transfused only with packed red blood cells.
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6. Appropriateness of Fresh frozen plasma transfusions:
Fig 7: Appropriateness of FFP as colloid in treating burns
When following Baxter’s original Parkland formula, in this study
population (n = 122), no FFP was transfused in the initial 24 hours of burn
injury. 206 units were transfused, at least, as double units (400 – 440 ml) in the
second 24 hours after burn injury and were considered appropriate.
235 units of FFP transfusions were considered inappropriate.
The reasons for inappropriate transfusions were:
i) Inadequate doses (less than 0.5 mL/kg/% TBSA and as single
doses).  100 units of FFP were transfused as single units.
ii) For treating hypoproteinemia
iii) To promote wound healing
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7. Appropriateness of platelet transfusions:
In this study population (n = 122), only one of the Burns patient was
transfused with one unit of random donor platelets. (An electrical burns patient
undergoing amputation of both upper limbs up to elbow, for whom 4 units of
red blood cells and 4 units of FFP were given followed by platelet transfusion,
with a platelet count of 49,000/cu. mm.). All the burns patients had their
platelet counts more than 10,000/cu.mm during their stay at hospital and all
platelet transfusions can be considered appropriate.
Table 7: Mean and standard deviation of platelet count in burns
patients:
Variable Minimum Maximum Mean Std.Deviation
Platelet count
(in cells/cu.mm)
(n = 122)
33000 660000 209762.30 106487.26
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II. AGE OF RED CELLS AND LENGTH OF STAY (LOS):
Table 8: Difference in mean LOS between non transfused patients and
transfused patients with variable storage age of RBCs:
Age of red cells – 7 days
Variable LOS ( in days) P value
Patients transfused with RBC units with <
7 days storage(n = 33/122)
29.6 (13.1)
P < 0.05
Patients who have not received RBC units
(n = 37/122)
13.19 (5.93)
Age of red cells – 14 days
Variable LOS ( in days) P value
Patients transfused with RBC units with <
14 days storage (n = 62/122)
27.6 (12.1)
P < 0.05
Patients who have not received RBC units
(n = 37/122)
13.19 (5.93)
Age of red cells – 21 days
Variable LOS ( in days) P value
Patients transfused with RBC units with <
21 days storage (n = 46/122)
27.47 (11.8)
P < 0.05
Patients who have not received RBC units
(n = 37/122)
13.19 (5.93)
Age of red cells – any day of storage
Variable LOS ( in days) P value
Patients transfused with RBC units with
any age of storage (n = 85/122)
26.39 (11.91)
P < 0.05
Patients who have not received RBC units
(n = 37/122)
13.19 (5.93)
In this study population (n = 122), the mean length of stay of
transfused burns patient was longer than the non-transfused burns patient,
irrespective of the storage age of red blood cells and it was statistically
significant (P < 0.05).
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Fig 8: Difference in mean Length of stay between patients who did not
receive RBCs (No RBC), RBCs of storage age < 14 days (RBC_2wks),
RBCs of storage age >14 days (RBC_4wks) and patients who received
RBC transfusions of any storage age (RBC_ ALL)
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Fig 9: Difference in mean Length of stay between patients who did not
receive RBCs (0), RBCs of storage age < 21 days (1), RBCs of storage age >
21 days (2) and patients who received RBC transfusions of any
storage age (3).
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Table 9: Difference in mean LOS in patients receiving RBCs of various
storage ages:
Variable
Age of red cells
Length of stay
(in days) Mean
(Std. Deviation)
P value
Patients receiving
RBC <14 days of
storage (n = 26/85)
22.03 (9.15)
> 0.05
Patients receiving
RBC >14 days of
storage  (n = 37/85)
23.04 (10.89)
Patients receiving
RBC < 21 days of
storage (n = 46/85)
24.09 (13.33)
> 0.05
Patients receiving
RBC > 21 days of
storage  (n = 9/85)
25.33 (14.93)
In this study population (n = 122), it was observed that the mean length
of stay of burns patients receiving red blood cells stored for greater than 14
days and 21 days was not significantly longer than those receiving red blood
cells stored for less than 14 days and 21 days respectively.
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III. OTHER PARAMETERS INFLUENCING LENGTH OF
STAY
1. Significance of correlating variables on Length of stay of Burns
patients:
Table 10: Correlation values and their significance of variables affecting
LOS:
Variable Pearson Correlation value P value
Total Body Surface
Area burns vs. LOS
0.049 > 0.05
Age of Burns patient
vs. LOS
0.102 > 0.05
APACHE II score vs.
LOS
0.260 < 0.05
APACHE II risk score
vs. LOS
0.288 < 0.05
APACHE II score vs.
Blood transfusion
0.190 < 0.05
Total component
transfusion vs. LOS
0.495 < 0.05
Total red cell
transfusion vs. LOS
0.453 < 0.05
In this study population (n = 122), using Pearson correlation it was
observed that the % TBSA and age of the Burns patient were not significantly
correlated to length of stay while APACHE II score, APACHE II risk score,
total component (whole blood, PRBC, FFP and PC units) transfusions and red
blood cell (Whole blood and PRBC units) transfusions were positively
correlated and statistically significant (P < 0.05).
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2. APACHE II score and Length of stay:
Fig 10: Correlation between APACHE II score and LOS
In this study population (n = 122), using Pearson correlation it was
observed that APACHE II score of the Burns patient and length of stay were
positively correlated (r = 0.260) and it was statistically significant (P < 0.05).
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3. Total blood components transfused and Length of stay:
Fig 11: Correlation between blood component transfusions and LOS
In this study population (n = 122), using Pearson correlation it was
observed that blood component transfusions in the Burns patient and length of
stay were positively correlated (r = 0.495) and it was statistically significant
(P < 0.05).
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4. Red blood cell transfusions and Length of stay:
Fig 12: Correlation between RBC transfusions and LOS
In this study population (n = 122), using Pearson correlation it was
observed that red blood cell (whole blood and packed cells) transfusions in the
Burns patient and length of stay were positively correlated (r = 0.453) and it
was statistically significant (P < 0.05).
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5. Fresh frozen plasma transfusions and Length of stay:
Table 11: Difference in LOS in patients transfused/not transfused
with FFP:
Variable
FFP transfusion
Length of stay
(in days)
Mean (Std. Deviation)
Pearson
Correlation
Transfused patients
(n = 114/122)
22.03 (11.37)
0.422
Non transfused patients
(n = 8/122)
27.37 (20.13)
In this study population (n = 122), using Pearson correlation it was
observed that fresh frozen plasma transfusions in the Burns patient and length
of stay were positively correlated (r = 0.422) and it was statistically significant
(P < 0.05). It was also observed that the mean length of stay for patients
transfused with fresh frozen plasma was significantly shorter than those who
were not transfused.
63
6. Wound infection in Burns patients:
Fig 13: Percentage of burns patients with culture proven wound infections
In this study population (n = 122), culture proven wound infections were
present in 103 patients.
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7. Microbes causing wound infection in Burns less than 48 hours:
16%
12%
7%
2%
3%
60%
Microbes cultured in first 48 hours of admission
Staphylococcus aureus (n = 15)
Klebsiella pneumoniae (n = 11)
Coagulase Negative
Staphylococcus (n = 6)
Pseudomonas aeruginosa (n =
2)
Enterococcus (n = 3)
No Growth (n = 55)
Fig 14: Microbes cultured in the first 48 hours of admission
8. Microbes causing wound infection in Burns from days 3 -7:
32%
28%
15%
4%
2%
2%
1% 1%
15%
Microbes cultured in days 3-7 of admission
Klebsiella pneumoniae (n =
64)
Staphylococcus aureus (n =
57)
Pseudomonas aeruginosa (n =
31)
Coagulase Negative
Staphylococcus (n = 9)
Enterococcus (n = 4)
Acinetobactor (n = 3)
Escherichia coli (n = 1)
Proteus species (n = 1)
No Growth (n = 31)
Fig 15: Microbes cultured in days 3-7 of admission
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9. Microbes causing wound infection in Burns from days 8-14:
Fig 16: Microbes cultured in days 8-14 of admission
10.Microbes causing wound infection in Burns more than 14 days:
Fig 17: Microbes cultured > 14 days of admission
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In this study population (n = 122), Staphylococcus species were the most
common organisms cultured in the first week of admission. From second week
of admission onwards, gram negative organisms (including Klebsiella species
and Pseudomonas species) were cultured more frequently.
11.Wound infection and Length of stay:
Table 12: Difference in mean LOS in burns patients with/without
wound infection
Variable
Wound infection
Length of stay
(in days)
Mean (Std. Deviation)
P value
Burns patients with wound
infection (n = 103/122)
24.8 (11.5)
P < 0.05
Burns patients without wound
infection (n = 19/122)
9.3 (3.2)
In this study population (n = 122), it was observed that the mean length
of stay for burns patients with culture proven wound infection was significantly
longer than those patients without wound infection.
67
12.Transfusions and wound infection in Burns patients:
Table 13: Difference in mean blood components transfused in patients
with/without wound infection:
Variable
No. of units
transfused
[Mean (Std.
Deviation)]
P value
Patients with wound infection and
received transfusions (n = 102)
6.31 (4.9)
0.03
Patients without wound infection and
received transfusions  (n = 19)
2.74 (1.6)
Patients with wound infection and
received whole blood transfusions (n = 70) 3.10 (2.4)
0.03
Patients without wound infection and
received whole blood transfusions  (n = 6) 1.00 (0.0)
Patients with wound infection and
received PRBC transfusions  (n = 39)
2.08 (1.47)
> 0.05
Patients without wound infection and
received PRBC transfusions  (n = 2)
2.00 (1.41)
Patients with wound infection and
received FFP transfusions (n = 94)
4.03 (2.33)
0.01
Patients without wound infection and
received FFP transfusions  (n = 18) 2.33 (1.14)
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In this study population (n = 122), among patients who were transfused
during their stay in the Burns ward (n = 121), those with culture proven wound
infections (n = 102) had received more blood component transfusions (total
components, whole blood and fresh frozen plasma) than those without wound
infection (P < 0.05). There was no significant increased use of packed red
blood cell units in burn patients with wound infection compared to those
without wound infection.
13.Wound infection in transfused burns patients and Length of stay:
Table 14: Difference in mean LOS in transfused burns patients
with/without wound infection
RBC
Transfusion
status
Variable
Wound infection
Length of stay
(in days)
Mean (Std.
Deviation)
P value
Transfused with
Red blood cells
(n = 85/122)
Burns patients with
wound infection
(n = 78/85)
27.76 (11.9)
P < 0.05
Burns patients
without wound
infection (n = 7/85)
11.14 (4.37)
Not transfused
with Red blood
cells
(n = 37/122)
Burns patients with
wound infection
(n = 25/37)
15.6 (5.73)
P < 0.05
Burns patients
without wound
infection  (n = 12/37)
8.17 (1.59)
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In this study population (n = 122), it was observed that the mean length
of stay for burns patients with culture proven wound infection who had
received RBC transfusions was significantly longer than those patients who did
not receive RBC transfusions.
14.Surgical procedures performed in Burns patients:
Fig 18: Surgical procedures performed in burns patients
28 patients had both Eschar removal and split skin grafting, while 6
patients had all three procedures viz. eschar removal, skin grafting and
amputation.
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15.  Surgical procedures and Length of stay:
Fig 19: Difference in mean LOS in patients undergoing surgery and
treated conservatively
In this study population (n = 122), it was observed that the mean length
of stay for burns patients undergoing surgical procedures was longer than those
patients treated conservatively.
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Table 15: Difference in mean LOS in RBC transfused patients undergoing
surgery and treated conservatively
RBC
Transfusion
status
Variable
Surgical procedures
Length of stay
(in days)
Mean (Std.
Deviation)
P value
Transfused with
Red blood cells
(n = 85/122)
Patients undergoing
surgery (n = 54/85) 31.15 (10.99)
P < 0.05Patients treated
conservatively
(n = 31/85)
18.09 (8.45)
Not transfused
with Red blood
cells (n=37/122)
Patients undergoing
surgery (n = 5/37) 17.8 (11.12)
P < 0.05Patients treated
conservatively
(n = 32/37)
12.47 (4.57)
In this study population (n = 122), it was observed that the mean length
of stay for burns patients who underwent surgical procedures and received
RBC transfusions was longer than those patients treated conservatively or with
no RBC transfusions.
72
DISCUSSIONS
I. PATIENT CLINICAL DETAILS:
1.  Age of the Burns patient:
The mean age of Burns patients in the present study (35.38 ± 12.93) was
similar to study by Gupta et al.14 (19.6) but studies by Hashmi et al.50 (22) and
Bain et al. 62 (26) showed a lesser mean age while Lu et al. 22 (48.3) showed a
higher mean age of burns patients.
2.  Sex of the Burns patient:
Male predominance in Burns (54%) seen in the present study was
similar to studies by Hashmi et al. 50 (57.8%) and Gupta et al. 14 (54%) but
other studies by Bain et al. 62 (66.8%) and Chakraborty et al. 61 (61.5%) showed
burns to be more common in females.
3.  Cause of Burns:
Thermal burns was more common in the present study (74%) which was
similar to other studies by Bain et al. 62 (80%) Gupta et al. 14 (72%) who
showed the predominance of thermal burns, but study by Tyson et al.17 (52%)
showed that scalds were the commoner cause of burns.
4.  Hemoglobin level at admission:
The hemoglobin level of the Burns patients at admission in the present
study (n = 122) was 12.53 gm/dL (SD - 2.49).  A study by Vincent et al.79 (n =
1136) showed lower hemoglobin level of 11.3 gm/dL (SD – 2.3) in Burns
patients during admission.
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II. APPROPRIATENESS OF BLOOD COMPONENT
UTILIZATION:
1.  Appropriateness of Red blood cell transfusions:
In the present study, 85 patients were transfused with 308 red cell units
of which nearly 50% of the burns patients (n = 43) were transfused with a
hemoglobin level below 10 gm/dL. The mean pretransfusion hemoglobin level
was 9.67 gm/dL for all transfused patients. This was higher than the mean pre-
transfusion hemoglobin level of 8.4 gm/dL in the study by Vincent et al. 79 but
even in their study, pre-transfusion hemoglobin level was greater than 9 gm/dL
in more than 30 % of the ICU patients.
The mean blood units transfused in Burns patients in this present study
(3.41 units) was comparable to other studies by Vincent et al. 79 (4.8 units) and
Lu et al. 22 (6 units). But other studies by Posluzny et al. 5 (16.6 units), Palmieri
et al. 39 (13.7 units) and Gupta et al. 14 (8 units) showed a higher mean number
of blood units transfused.
Most of the red cells transfused in burns patients in this present study
belonged to second and third week of storage, which was similar to mean
storage age of 16.2 days in the study by Vincent et al. 79 and 16-21 days by
Aubron et al.47
The patient profiles in the present study had varied, from a patient who
was conservatively managed without any blood component transfusion to an
electrical burns patient, who was transfused with 25 units of red cells, 7 units of
fresh frozen plasma and 1 unit of platelets and underwent 4 surgical
procedures.
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Use of blood components when are they are not necessary, for example
patients with minor or partial thickness burns, who can be managed with only
fluids, constitutes inappropriateness. As literatures suggest, burns up to 25%
TBSA can be managed with only fluids (oral/intravenous) unless the precarious
condition of the burns patient warrants transfusions.24, 27, 28, 29  This is true
especially in patients with electrical burns who may need amputation to save
limb or life, and transfusions are inevitable. Burns patients can have a fall in
haemoglobin levels not only during surgical procedures but also later due to
anemia of critical illness.
Hemoglobin levels in burns can be spuriously high, due to the profound
fluid loss leading to hemoconcentration, which may mask the underlying
anemia. Adequate hydration will show the true picture, at which time the
anemia can lead to complications.
Various studies have shown the efficacy of restricted hemoglobin
triggers (Hb between 7-9 gm/dL and maintaining hemoglobin of 8-10 gm/dL)
when compared to liberal transfusion triggers (Hb around 10 gm/dL and
maintaining hemoglobin levels between 10-12 gm/dL) in critically ill patients.
Patients are usually transfused with single red cell units with frequent
monitoring in-between transfusions.
According to recommendations, when a hemoglobin trigger of 10 gm/dL
is applied, 64% of all red cell transfusions can be considered appropriate.
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The reasons for the inappropriate red cell transfusions included, blood
loss during surgical procedures, bleeding burns patients and other co-morbid
conditions like ischemic heart disease and diabetes mellitus. In the present
study, 47 red blood cell units were transfused to burns patients with a
hemoglobin level greater than 10 gm/dL, during surgical procedures.
The reasons for red blood cell transfusion in burns patients with
hemoglobin level of 10 gm/dL included: the patient’s anemia masked by
hemoconcentration, surgeon’s helplessness in estimating the rate and amount of
bleeding during burns surgery and the anesthetist’s reluctance to wait till Hb
reaches below 8 gm/dL.
French et al.54 in their study with hemoglobin trigger of 10 gm/dL found
only 3% inappropriate transfusions whereas Afzal et al.55 in his study in
patients with hemoglobin less than 10 gm/dL, found 54.1% appropriate
transfusions.
In the present study, most of the red blood cell transfusions were whole
blood (n = 223). Whole blood is transfused in the belief that it will provide all
components of blood and thus will aid in wound healing. As the present study
shows, the mean hospital length of stay was not significantly shorter for
patients transfused with whole blood, when compared to those patients who
were transfused with PRBC. So, the use of whole blood should be curbed with
rational use of blood as components.
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2. Fluid management in burns patients and role of Fresh frozen
plasma:
Till the 1950s, burns involving even 10 – 20 % TBSA were associated
with high mortality. It was then the importance of fluid management in burns
was understood and the first fluid resuscitation protocol was given by Evans in
1952. After many trials in the 1960s, Charles Baxter gave the widely acclaimed
Parkland formula (1974) for fluid resuscitation in burns patients. This formula
holds good even today, and is followed all over the world with minor
modifications.33
The original Parkland formula had incorporated fluid management with
only crystalloids during the initial 24 hours after burn injury and management
with colloids (Fresh frozen plasma) during the second 24 hours after burns.
When a consensus was explored, the initial 24 hours fluid resuscitation with
crystalloids was accepted but the next 24 hour resuscitation with colloids was
not considered. But fresh frozen plasma was still used in burn resuscitation as a
colloid till the end of 1980s when the HIV epidemic shook the world with a
high risk of transmission by transfusion. So, rational use of blood and blood
products was advocated and use of FFP for volume resuscitation was held
inappropriate.34
When alternatives to FFP were searched, 5% albumin, dextran and
hydroxyethyl starch were introduced with much promise. 5% Human albumin
is the most commonly advocated and used colloid for late fluid management in
burns. It is iso-oncotic and has a half-life of about 20 days. 84 Even though
effective in hypovolemia and hypoproteinemia (25%), the multiple indications
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for which Human albumin was supposed to be helpful have been questioned in
recent trials and observations. The recent meta-analysis by Cochrane review
group had found that use of albumin had not reduced mortality when compared
to crystalloids but rather suggested an increased risk of mortality in burns
patients. These effects were attributed to the prolonged heat treatment of
albumin (10 hours at 60 0C) which made the molecules more permeable with
loss of electronegative charge. Thus albumin inhibits platelet aggregation and
enhances inhibition of factor Xa by Anti-Thrombin III.31
In India, the price of 20% human albumin was 4904 rupees. But ever
since the Indian Drug Price Control Order (DPCO) 2013 by National
Pharmaceutical Pricing Authority (NPPA) brought it under essential drug list,
there has been a shortage for human albumin solutions.35
Dextrans were helpful in hypovolemia by having a long intravascular half
life but had significant adverse effects like anaphylaxis, pulmonary edema,
platelet disorders and acute renal insufficiency.
Hydroxylethyl starch showed much promise in hypovolemia but the
FDA had issued a black box warning in 2013 restricting its use in critically ill
with sepsis with a risk of acute renal insufficiency. There is also an increased
risk of bleeding as patients transfused with dextran showed a 50% fall in factor
VIII levels.36
In such a scenario, the limited availability of albumin and its prohibitive
cost has made the clinicians turn back to fresh frozen plasma as a colloid. FFP
contains 0.025 g of albumin/mL, 84 while 5% albumin contains 0.05 g of
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albumin/ mL. The adequate dosage of FFP is 0.5 ml/kg/% TBSA, which is
necessary to derive the desired effects of FFP as a colloid. In the present study,
FFP was mostly given as two units prepared from 350 ml of whole blood (total
dose of 400-450 ml) which was equivalent to a dose of 200 ml of 5% albumin.
The dose of plasma to increase albumin by 0.5 g/dL is approximately
20–30 mL/kg/day, assuming no extraordinary loss or metabolism.84 This
necessitates a large volume of plasma to be transfused especially in burns
patients, who are already in a hypermetabolic state. Thus FFP is not suitable for
treating hypoalbuminemia.
Fresh frozen plasma contains not only albumin (albeit in smaller
amounts) but other procoagulant factors like fibrinogen, anti-proteases and also
fibronectin which gives it an added advantage. But FFP has its own demerits in
risk of transfusion transmitted infections and transfusion related
immunomodulation. Sarani et al.83, in their study involving 2267 ICU patients,
have found that infectious episodes were more common in those transfused
with fresh frozen plasma when compared to non-transfused patients.
FFP replenishes fibrinogen and other coagulant factors in burns patients.
It also contains fibronectin, shown to be decreased in burns patients, which has
opsonic activity and reinforces leukocyte activity in burns. Fibronectin in FFP
transfused to burns patients has been shown to decrease incidence of sepsis for
about 24 hours after transfusion.85
If the FFP appropriate transfusion guidelines are applied, all the
transfusions used for burns as in the present study would seem inappropriate.
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But on applying the Baxter’s original Parkland formula for late fluid
resuscitation in burns which uses FFP as the colloid, we found 47% of the
transfusions to be appropriate. This is similar to the 52% inappropriate FFP
transfusion results obtained by Kulkarni et al. in 945 patients with 1884 FFP
transfusions. 56 The reasons for inappropriate transfusions were high cost and
unavailability of 5% albumin, use for hypoproteinemia and to aid wound
healing.
The risk of TTI can be reduced by stringent donor selection, advanced
screening technologies like Nucleic Acid Testing, pathogen reduction
technology; risk of TRALI can be reduced by preparing FFP from
predominantly male donors and nulliparous female donors;51 and risk of TRIM
can be reduced by leukofiltration. If risks are minimized, fresh frozen plasma
can be more beneficial than detrimental in burns management as shown by
Fodor et al.28
In the present study, the mean length of stay was significantly shorter for
patients transfused with fresh frozen plasma when compared to those patients
who were not transfused with FFP. This result is in contrast to the study by
Sarani et al. 83, which showed that the LOS was prolonged in critically ill
patients who were transfused with FFP. This finding should not be interpreted
that FFP was beneficial for burns in this study but rather it signifies the
beneficial effect of colloids in the late fluid management of burns. One other
reason was that even though the patients had not received FFP, they had
received RBC units and underwent surgery. This may have prolonged the mean
LOS of the patients who were not transfused with FFP.
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Thus, in managing 15 – 40% burns crystalloids are the mainstay of
treatment. Colloids are used only when crystalloids are inadequate in
maintaining fluid volume or when complicated by fluid creep.
In a resource limited country like India, use of FFP as a colloid
replacement is still indispensable, until other colloids (5% albumin or HES)
become freely available in market at an affordable cost. Even then, colloids are
advised only when the benefits outweigh risks.
3.  Appropriateness of platelet transfusions:
 It is well known fact that thrombocytopenia is encountered in the first
week of burns injury but it reaches normal levels in the second week. Hence
platelet transfusions are usually not indicated for the initial fall in platelet
counts. Gajbhiye et al.65 in their study on 594 burns patients, have found that
serial decline in platelet count was a bad prognostic indicator of septicemia in
Burns patients. Such patients need, in addition to treatment like hydration and
antibiotics, blood transfusions. Platelet transfusions are not usually indicated in
surgical patients till the platelet count falls below 50,000/cu.mm of blood.51 In
the present study, only one patient was transfused with one unit of platelets
during limb amputation surgery for electrical burns along with 4 units of RBCs
and 4 units of FFP (with a platelet count of 49,000/cu. mm). The minimum
platelet count encountered in this present study was 33,000/cu. mm. for which
no platelet transfusion was given. Hence all transfusions regarding platelet
requirements can be considered appropriate. Schofield et al.59 showed a 67%
appropriate platelet transfusions in 1147 patients from 14 public hospitals in
New South Wales.
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III. PARAMETERS INFLUENCING LENGTH OF STAY:
With better accessibility to tertiary care with Emergency Medical
Services (EMS) vehicles and long strides in Burns injury care, more Burns
victims are surviving and so quality of life parameters are taking prominence
over mortality parameters. Length of hospitalization is one of the easily
monitored and accessible parameters, which gives a better view on burns care
and patient survival. But length of hospital stay is influenced by multiple
factors from patient demographics to transfusion, surgery and sepsis. When
multivariate analysis is undertaken, exclusion of non-survivors from analysis
can help identify prognostic factors for hospital Length of stay.85 Thus, this
study includes only patients who are discharged from hospital after treatment.
1.  Length of stay:
The mean length of stay of Burns patients in the present study (n = 122)
was 22.39 with a minimum and maximum stay of 6 days and 63 days. The
study by Gupta et al.14 showed a higher mean length of stay of 57 days while
Bain et al.62 showed a lower mean length of stay.
2. Age of the Burns patient:
In the present study, even though age of the Burns patient was positively
correlated to hospital length of stay, it was not statistically significant. This is
similar to the result obtained by Posluzny et al.5 who did not find correlation
between age and LOS but in contrast to the studies by Edgar et al.63  and
Hussain et al.85 whose studies showed that advancing age was a significant
factor for prolongation of hospital length of stay.
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3. Total Burnt Surface Area:
 In the present study, total burnt surface area (TBSA) was taken as 15-
40% because, below 15% TBSA burns, hospitalizations are rarely necessary
and in burns above 40%, mortality risk is higher.8,20 Hussain et al.85, in their
review have shown that % TBSA is a better predictor of hospital LOS. As the
present study results show, the restricted TBSA of 15-40% was not
significantly correlated to length of stay and hence the confounding factor of
TBSA burns was overcome and the significance of other factors became
absolute.
4. APACHE II score:
APACHE II score which was developed as a mortality predictor also
doubles up as a morbidity predictor. As the % TBSA has been restricted in the
present study, the APACHE II score obtained was low (maximum score 15).
Still APACHE II score and the APACHE II risk score showed a positive
correlation to length of stay which was statistically significant.
5. Blood component transfusions:
In the present study, it was observed that as the number of blood
transfusions increase in the burns patient, there was a significant prolongation
of hospital length of stay. The results were similar to those obtained by Neamtu
et al.41, Palmieri et al.39, Malone et al. 80, Vincent et al.79 and Roubinian et al. 53
Burns patients receiving blood transfusions showed a significant
positive correlation to APACHE II score at admission, which was similar to the
studies by Posluzny et al. 5 and Vincent et al. 79 who showed that transfused
patients had higher APACHE II scores.
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6. Storage age of Red Blood Cells:
Many observational studies and clinical trials have tried to prove the
deleterious effects of increasing storage age of red cells but none have given
conclusive results. While Pettila et al. 44 showed increased mortality in the
critically ill patients transfused with older red blood cells; AABB technical
manual and the Cochrane review 2015 have not found any clear differences in
clinical outcomes between fresher and older red blood cells. 45, 46 The present
study also did not find any significant prolongation of mean hospital length of
stay among two groups (receiving initial 14 days stored RBCs vs. more than 14
days stored RBCs, receiving initial 21 days stored RBCs vs. more than 21 days
stored RBCs). But there was significant prolongation of mean hospital length
of stay in transfused burns patients when compared to non-transfused burns
patients, irrespective of storage age of red cells.
7. Wound infection:
In the present study, 103 burn patients had culture positive wound
infections of which Staphylococcus species were the most common organism
cultured in the first week of admission. From second week of admission
onwards, gram negative organisms including Klebsiella species and
Pseudomonas species were cultured more frequently. These results are similar
to the other studies by Church et al.6 and Khaliq et al.12 who showed gram
positive organisms in the first 48 hours by colonization from skin flora and
gram negative organisms after 5-7 days of burn injury by colonization from
enteral flora.
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In the present study, wound infection in Burns patients was significantly
associated with prolonged stay in hospital which was in contrast with study by
Khaliq et al. 12 who reported that colonization of wounds by micro-organisms
were not culprits in prolongation of hospital stay. In the review article on burn
wound infections, Church et al. 6 emphasizes that multi drug resistant microbes
increase length of hospitalization.
8. Influence of transfusion on wound infection:
In the present study, burns patients with culture proven wound
infections had received more blood components than those without wound
infection. These results were similar to the study results from Palmieri et al.39
who showed that blood transfusion increased the risk of infection by 13% per
unit transfused. Also, Lelubre et al.1 in his review has identified RBC
transfusion as an independent predictor of infections in the critically ill
patients.
The increased susceptibility for wound infections can be explained by
the immunomodulation normally seen after acute burn injury which is
compounded by transfusion related immunomodulation (TRIM). The normal
host defense response is suppressed by an increasing concentration of
suppressive interleukins like IL-4, IL-10 and PGE2.5 This has dual responses,
one of which is better skin graft uptake and the other is susceptibility to
microbial invasion. Even though immunosuppression after burn injury is
ubiquitous, blood transfusion further compromises the immune system,
increasing the susceptibility to microbial infection and affecting mortality and
morbidity. 39
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9. Surgical Procedures:
In the present study, 59 patients underwent 119 surgical procedures of
which the commonest surgery was eschar removal 32% (n = 59). Next common
surgery was split skin grafting 26% (n = 48). These were similar to the results
obtained in the study by Palmieri et al. 39 who showed that eschar removal was
the common surgery in 30% of burn patients. But results from Gupta et al. 14
study showed that split skin grafting (46.6%) was the most common surgery
followed by eschar removal (36.5%).
In the present study, patients who underwent surgical procedures
received more blood transfusions than those treated conservatively. These
results were similar to the findings by Posluzny et al. 5 who showed that
transfusions were significantly correlated with number of operative procedures.
In the present study, Burns patients undergoing surgical procedures had
a significantly prolonged length of hospital stay when compared to those
patients treated conservatively. These results were similar to those obtained in
the study by Hussain et al. 85 and Gupta et al. 14. Gupta et al. study showed that
while Burns patients treated conservatively had a mean length of stay of 24
days (±18), patients treated with surgical procedures had a mean length of stay
of 62 days (±26).
Thus, the factors significantly increasing length of stay (and thus wound
healing) of burns patients in the present study include APACHE II score at
admission, RBC transfusions, surgical procedures and wound infections. The
factors not found to significantly influence length of stay (and thus wound
healing) were age of the burns patient, sex, and storage age of red blood cells.
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FLUID MANAGEMENT IN BURNS - ALGORITHM
Emergency management (ABC) of
the Burns patient
Intravenous lines in non-burnt skin
Calculation of TBSA, weight
Fluid Replacement – Original Parkland Formula:
[Initial 24 hours] - 4 ml/kg body weight x TBSA for 24 hours.
1st half within 8 hours of burn injury, 2nd half in the remaining 16
hours
Choice of Fluid: Ringer’s Lactate24
[2nd day onwards (i.e. after 24 hours)]; 2ml/kg body weight x
 TBSA, replacement according to the hydration status
 (fluid Input Output chart (IDR), Blood Pressure, approximate
calculation of fluid loss through burns wound surface, hematocrit,
hypo/hypernatremia)30
Total daily maintenance fluids following burns shock is given by
formula:
Basal (1500 cc/m2) + evaporative water loss [(25 + % burn) x m2 x
24]
(*m2 = total body surface are in square meters). Can be intravenous or
enteral.
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Intake Diuresis Ratio (IDR) - [based on fluid intake (intravenous and
oral), urine output, transdermal fluid loss, insensible fluid loss]
(The transdermal fluid loss - calculated as 40 ml/% TBSA/day)30
Use of Colloid in burns Patients
Colloid administration should be considered only after 24 hours of burn
(24hrs post-burn). When urine output is maintained between 30-50 ml/ hr (or
1ml/kg/hr) for 2 hours, reduce crystalloids (RL) dose by 10%, to avoid fluid
creep. 24
Be vigilant about excess urine output i.e. more than 1ml/kg/hr which
might lead to fluid creep and compartmental syndrome (mainly Abdominal
Compartment Syndrome), eventually leading to death. However, there are
studies which support careful usage of colloids in the following situations: 24
i.  Patients with burns of more than 20% TBSA are definitely at risk for
developing burns shock. In burns involving more than 25% TBSA,
capillary permeability is increased both in burnt and non-burnt areas
leading to fluid creep. This is likely to result in resuscitation
morbidity (anasarca/ orbital compartmental syndrome/ extremity
compartmental syndrome/ abdominal compartment syndrome/
pulmonary edema, pneumonia/ septicemia/ ARDS/ multiorgan
failure or death)
ii.  Colloid, whether given as plasma, albumin or hetastarch is
significantly more expensive than crystalloids.
Fresh Frozen plasma is probably the best colloid solution available
for acute burn resuscitation, 28 particularly whenever there is a serious
coagulopathy risk
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Indications for colloids in resuscitating Burns patients:
Patients requiring more fluid volumes than predicted by the parkland
formula [(i.e. > 4ml/kg x TBSA/day) may get a third of their hourly fluid
volumes as colloids (5% albumin) 24/ hetastarch/ Fresh Frozen Plasma]
Projected 24 hr resuscitation exceed 6ml/kg/hr near the 12 hr mark
Resuscitation volume more than 237 ml/kg over 12hrs (16 lts during a 12 hr
period in 70 kg man) appears to be the threshold for the development of
ACS.
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SUMMARY
In our study,
I. On appropriate use of blood components
? 122 Patients who were admitted to the Department of Burns, Plastic and
Reconstructive Surgery, Kilpauk Medical College with 15 – 40% burns
were followed for a period of one year from September 2014 to August
2015.
? Mean age of the study group was 35 years and 54% were males
? The most common cause of burns was thermal burns (74%).
? Mean Hemoglobin level at admission was 12.53 gm/dL.
? 121 out of 122 patients had received atleast one blood component.
? 85 patients had received red blood cell transfusions. A total of 308 red
blood units were utilized. Out of these 308 units, 167 belonged to
second and third week of storage.
? The mean pre-transfusion hemoglobin level was 9.67 gm/dL. A mean of
3.41 red blood cell units were utilized in transfused burns patient.
? While following New York State Council guidelines for transfusion of
RBCs in Burns 2012, when a hemoglobin trigger of 10 gm/dL was
applied, 64% of red blood cell transfusions (n = 198) were considered
appropriate.
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? 223 units of whole blood were utilized in this study population.
? When following Baxter’s original Parkland formula for fluid
management in Burns, 47% of all FFP transfusions (n = 206) were
considered appropriate. Of the 235 inappropriate FFP transfusions, 100
were of single unit transfusion.
? Only one patient was transfused with platelet concentrate (a case of
electrical burn injury who underwent upper limb amputation with
platelet count of 49,000/?L). All other patients had their platelet count
above 10,000/ ?L and were not transfused.
? Burns patients with wound infection had received a mean of 6.31 blood
components while those without wound infection had received a mean
of 2.74 blood components. (P < 0.05)
II. Factors influencing Length of Stay (LOS)
? The mean length of hospital stay was 22.39 days.
? APACHE II was positively correlated to LOS. (P < 0.05)
? The mean LOS of patient transfused with red blood cells was 26.39 days
while patients who did not receive RBC transfusion had a mean LOS of
13.19 days. (P < 0.05)
? The mean LOS of patients receiving RBC units stored for < 14 days was
22.03 days while patients who received RBC units stored for > 14 days
was 23.04. (P > 0.05)
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? The mean LOS of patients receiving RBC units stored for < 21 days was
24.09 days while patients who received RBC units stored for > 21 days
was 25.33. (P > 0.05)
? The mean LOS of burns patients with wound infection was 24.8 days
while patients who did not develop wound infection had a mean LOS of
9.3 days. (P < 0.05)
? Mean LOS of burns patients with wound infection who had received
RBC transfusion was 27.76 days. Mean LOS of burns patients with
wound infection who had not received RBC transfusion was 15.6 days.
(P < 0.05)
? The mean LOS of patients who underwent surgical procedures was
30.02 days while patients who were treated conservatively had a mean
LOS of 15.24 days. (P < 0.05)
? Mean LOS of burns patients who underwent surgical procedures and
had received RBC transfusion was 31.15 days. Mean LOS of burns
patients with wound infection who had not received RBC transfusion
was 15.6 days. (P < 0.05)
? Age and % TBSA did not show significant correlation to LOS.
? The factors found to significantly increase length of stay of burns
patients include APACHE II score at admission, blood transfusions,
surgical procedures and wound infections. The factors not found to
significantly influence length of stay were age of the burns patient, sex
and storage age of red blood cells.
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CONCLUSION
In our study, by following hemoglobin trigger of 10 gm/dL for burns
patients, use of red cell concentrate in 64% transfusions were considered
appropriate. However, the remaining 36% were considered inappropriate
because they were transfused for higher Hemoglobin values and with an aim to
achieve faster wound healing.
In a country like India, considering the cost of 5% Albumin, as per
original parkland formula, 47% of FFP transfusions were appropriate. The
remaining 53% were considered inappropriate, because most of the units were
transfused after 48 hours of burn injury and number of units transfused was
inadequate for the expected dose of albumin to be replaced.
As in other studies, in our study also Length of Stay for burns patients
significantly increases following blood component transfusion. Hence,
judicious use of blood and blood components in burns patients must be
emphasized.
Further, our study reiterates that there is no significant correlation
between LOS and storage age of red cells in burns patients. This is contrary to
the wider belief of using fresher whole blood to reduce length of hospital stay
in burns patients.
Successful outcome of burns patients purely depend on proper wound
care, along with appropriate use of fluids and blood components.
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LIMITATIONS
? Burns patients with TBSA of more than 40% could have been included.
? If the patients were affordable, comparison of FFP transfusion with 5%
albumin could have been done.
? Since patients with >40% TBSA were not included, appropriate use of
platelet concentrates and other components like cryoprecipitate couldn’t
be studied.
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PATIENT INFORMATION SHEET
EVALUATING THE APPROPRIATENESS OF BLOOD COMPONENT
UTILIZATION IN BURN PATIENTS
       Burn injuries are a major public health problem due to its high mortality, morbidity and
disability. This study is done to evaluate the appropriateness of Blood component utilization
in Burn patients and to form a protocol for transfusion of blood components.
PROCEDURE
      Data will be collected from Case records, Blood request forms and Blood Bank records
for analysis.
BENEFITS AND RISKS
      There is no risk for patients enrolled in this study as their treatment protocols are not
interfered with.
CONFIDENTIALITY
      Your privacy will be protected in so for as permitted by law. Only your researcher and
Ethical committee members will have access to the data collected during the study.
PARTICIPATION
     Your participation in this study is voluntary and you are free to decide now or later
whether to continue or discontinue from the study.
CONSENT
I confirm that I read and understood the information about the above research study
dated ______________ and I received chance to ask the questions.
My participation in this study is voluntary and I know that I am free to withdraw from
the study at any time, without giving any reason and without affecting of my legal
rights.
I agree to this access. I know that my identification will not be revealed in any details
that is released to third persons or published.
I agree not to restrict or interfere with any data or results that are obtained from this
study. I agree to participate in this research study for the above listed purpose.
Patient’s name                     :
Signature                              :                                                             Date    :
Patient IP Number               :
Signature of the person
who obtains consent            :                                                              Date    :
gq;Nfw;ghsu;f;fhd jfty; gbtk;.
        jPf;fhak; fz;l NehahspfSf;F ,uj;jf;$Wfs; nrYj;Jtjpd;
Kiwahd jd;ik Fwpj;J fz;lwpAk; Ma;T.
Fwpf;Nfhs:;
       jPf;fhak; fz;l NehahspfSf;F  nrYj;jg;gLk;  ,uj;jf;$Wfs;
kw;Wk; mtw;wpd; Kiwahd jd;ik fz;lwpjy;.
nra;Kiw:
Nehahspfspd; kUj;Jtkid Fwpg;NgLfs; ,uj;jf;$Wfs; Ntz;b
tpz;zg;gq;fs ; kw;Wk; ,uj;j tq;fpapy; cs;s Fwpg;Gfs; Mfpait ngwg;gl;L
Ma;Tf;F cl;gLj;jg;gLk;.
gyd;fSk; ghjpg;GfSk;:
              jPf;fhak; fz;l NehahspfSf;F  ,uj;jf;$Wfs;
nrYj;Jtij ,e;j Ma;T  Kiwg;gLj;j cjTk;. Nehahspfspd; rpfpr;ir
KiwapNyh ,uj;jf;$Wfs; nrYj;jg;gLtjpNyh Muha;r;rpahsu;
jiyapLtjpy;iy. Mifahy; NehahspfSf;F  vt;tpj ghjpg;Gk; ,y;iy.
,ufrpag; ghJfhg;G:
         rl;l tiuKiwapd;gb jq;fspd; nrhe;j tp\aq;fs; ghJfhf;fg;gLk;.
jq;fspd; Muha;r;rpahsH kl;Lk; ,e;j Muha;r;rpapd; NghJ fpilf;Fk; Gs;sp
tptuq;fis gad;gLj;j ,aYk;.
gq;fspg;G:
         ,e;j Muha;r;rpapy;  jq;fspd;   gq;fspg;G jd;dhu;tkhdJ. ,e;j
Muha;r;rpapy; jq;fspd;   gq;fspg;gpidj; njhlu;tjw;Fk;> tpLgLtjw;Fk; ve;j
NeuKk; jq;fSf;F cupikAz;L.
Nehahspapd; ngau;:
ifnahg;gk;:
Njjp:
Patient
ID
Age
(in yrs)
Sex
TBSA
(in %)
Bl gp
Rh typ
Hgb
(in
gm%)
Plt count
(in cells/
cu.mm)
aPTT (in
sec) N:-
30 - 40
sec)
WB
units
PRBC
units
FFP
units
(> 24
hrs
post
burn)
PC
(RDP
units)
WB + PRBC
(units)
Appropriat
eness of
RBC Txn
Appropriate RBC
Txn (No. Of units)
(Hb < 10 gm%, Hb
> 10 gm%,
surgery/
impending
bleeds)
Inappropriate
RBC txn (No.
Of units) (> 10
gm%, no
surgery/
impending
bleeds)
Appropriat
e FFP Txn
Inappropriate
FFP Txn
Outcome
B001 45 M 18 B pos 12.9 155000 32 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B002 61 M 15 B pos 10.7 330000 34 1 0 2 0 1 App. Txn 1 0 0 2 Survived
B003 38 M 25 A pos 15 276000 32 1 0 8 0 1 Inapp. Txn 0 1 4 4 Survived
B004 20 M 27 O pos 16.1 209000 33 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B005 65 M 27 B pos 13 94000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B006 26 M 23 B pos 17 145000 37 17 8 7 1 25 Both App and Inapp 23 2 4 3 Survived
B007 30 F 38 O pos 13.9 220000 38 7 0 8 0 7 Both App and Inapp 6 1 3 5 Survived
B010 35 M 39 A pos 16 165000 32 1 0 0 0 1 Inapp. Txn 0 1 0 0 Survived
B011 72 F 21 O pos 10.1 197000 36 0 2 1 0 2 App. Txn 2 0 0 1 Survived
B012 30 F 27 O pos 13 100000 39 3 3 3 0 6 App. Txn 6 0 0 3 Survived
B013 25 F 33 O pos 9.3 209000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B014 16 F 15 B pos 10.8 179000 36 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B015 25 F 26 B pos 13.1 122000 32 3 0 2 0 3 App. Txn 3 0 0 2 Survived
B016 35 M 40 O pos 14.1 79000 39 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B017 33 M 25 O pos 11.3 129000 34 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B018 32 M 27 O pos 12 110000 33 0 0 0 0 0 No RBC Txn 0 0 0 0 Survived
B019 29 M 17 B pos 13 495000 31 3 0 0 0 3 App. Txn 3 0 0 0 Survived
B020 46 M 20 A pos 16 141000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B021 22 M 15 O pos 14.5 127000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B022 42 F 17 B pos 14.8 276000 31 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B024 27 M 28 O pos 12.4 366000 32 0 0 2 0 0 No RBC Txn 0 0 0 2 Survived
B025 23 F 20 B pos 13 249000 34 2 2 1 0 4 Both App and Inapp 3 1 0 1 Survived
B027 29 F 32 AB pos 9.9 300000 36 5 0 3 0 5 App. Txn 5 0 2 1 Survived
B028 46 M 18 B pos 8.5 387000 37 5 1 0 0 6 Both App and Inapp 5 1 0 0 Survived
B029 40 M 27 B pos 14 239000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B030 19 M 36 AB pos 10.1 179000 33 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B031 40 M 19 O pos 9 159000 32 2 2 0 0 4 App. Txn 4 0 0 0 Survived
B032 40 M 30 A pos 12.5 112000 37 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B033 24 M 31 B pos 15.1 222000 35 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B034 27 F 27 O pos 14.4 278000 34 1 0 4 0 1 App. Txn 1 0 2 2 Survived
B035 28 F 26 B pos 11 251000 34 3 1 2 0 4 App. Txn 4 0 2 0 Survived
B036 21 F 28 A pos 14.3 265000 35 1 1 6 0 2 App. Txn 2 0 4 2 Survived
B037 55 F 25 A pos 12 186000 33 3 0 10 0 3 App. Txn 3 0 4 6 Survived
B038 50 F 20 B pos 14 33000 38 2 1 2 0 3 App. Txn 3 0 0 2 Survived
B039 17 F 21 O pos 13.9 445000 32 3 0 2 0 3 Both App and Inapp 2 1 2 0 Survived
B040 55 M 23 B pos 9.2 106000 33 4 1 6 0 5 App. Txn 5 0 2 4 Survived
B041 37 M 33 B pos 11.4 192000 34 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B042 34 M 34 O pos 16 177000 35 4 2 3 0 6 Both App and Inapp 3 3 2 1 Survived
B043 33 M 22 O pos 15.6 164000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B044 60 F 29 B pos 8 151000 36 2 2 4 0 4 App. Txn 4 0 2 2 Survived
B046 38 F 32 O pos 11 259000 34 6 3 5 0 9 Both App and Inapp 5 4 2 3 Survived
B048 24 F 36 O pos 12 34000 38 4 4 5 0 8 App. Txn 8 0 2 3 Survived
B049 28 F 30 B pos 11.4 125000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B050 29 F 30 O pos 13 217000 34 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B051 60 M 26 O pos 12.6 209000 35 1 2 3 0 3 App. Txn 3 0 2 1 Survived
B052 48 M 23 O pos 15 442000 38 0 2 2 0 2 Inapp. Txn 0 2 2 0 Survived
B053 54 M 24 B pos 11 341000 38 1 0 4 0 1 Inapp. Txn 0 1 2 2 Survived
B054 40 F 40 B pos 13.3 349000 37 2 0 2 0 2 App. Txn 2 0 2 0 Survived
B055 39 F 31 A pos 12.9 212000 36 3 0 5 0 3 Both App and Inapp 1 2 3 2 Survived
B056 38 F 33 B pos 13.5 221000 37 3 1 5 0 4 Both App and Inapp 3 1 3 2 Survived
B057 45 M 15 A pos 14.5 194000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B058 50 M 25 O pos 15 131000 35 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B059 31 M 17 O neg 14.3 190000 36 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B060 28 F 25 O pos 8.5 285000 37 0 1 0 0 1 App. Txn 1 0 0 0 Survived
B061 24 F 32 A neg 11.2 237000 38 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B062 61 F 20 O pos 11.2 54000 36 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B063 25 F 25 B pos 14.3 138000 33 4 1 5 0 5 App. Txn 5 0 0 5 Survived
B064 18 F 25 B pos 15.9 572000 32 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B065 29 F 34 B pos 11.9 297000 34 4 4 11 0 8 App. Txn 8 0 4 7 Survived
B067 40 M 20 B pos 10.8 483000 37 4 3 6 0 7 App. Txn 7 0 3 3 Survived
B068 36 F 33 B pos 12.7 273000 35 2 0 6 0 2 App. Txn 2 0 3 3 Survived
B069 45 M 18 A pos 11.1 448000 32 2 2 4 0 4 Inapp. Txn 0 4 0 4 Survived
B070 26 F 26 AB pos 10.5 100000 33 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B071 81 F 27 O neg 6.6 174000 34 0 2 2 0 2 App. Txn 2 0 2 0 Survived
B072 26 F 30 B pos 11.5 236000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B073 40 F 30 B neg 10.7 111000 34 2 1 2 0 3 Both App and Inapp 2 1 2 0 Survived
B074 19 F 20 AB pos 9.5 210000 33 4 0 6 0 4 Both App and Inapp 2 2 2 4 Survived
B075 26 F 26 O neg 13.2 190000 33 2 1 8 0 3 Both App and Inapp 2 1 3 5 Survived
B076 23 M 19 A pos 12 154000 34 7 1 8 0 8 Both App and Inapp 2 6 2 6 Survived
B077 32 F 25 O pos 14.6 290000 34 1 0 4 0 1 App. Txn 1 0 2 2 Survived
B078 38 M 27 B neg 15.9 390000 32 3 0 10 0 3 Both App and Inapp 2 1 6 4 Survived
B079 33 M 36 A pos 16.5 256000 33 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B080 18 M 38 O pos 7.4 264000 33 1 3 2 0 4 App. Txn 4 0 2 0 Survived
B081 30 F 32 O pos 9.7 103000 34 4 0 8 0 4 App. Txn 4 0 4 4 Survived
B082 42 M 20 O pos 16.3 277000 32 1 0 4 0 1 App. Txn 1 0 0 4 Survived
B083 22 M 31 A pos 15.4 95000 31 0 2 8 0 2 Both App and Inapp 1 1 2 6 Survived
B084 27 M 30 O pos 12.4 157000 32 5 0 8 0 5 Both App and Inapp 4 1 2 6 Survived
B085 40 M 19 A pos 12 146000 33 7 1 7 0 8 App. Txn 8 0 4 3 Survived
B086 30 M 30 O pos 14.3 132000 32 2 0 8 0 2 Both App and Inapp 1 1 4 4 Survived
B087 35 M 22 A pos 12.3 660000 31 2 0 4 0 2 App. Txn 2 0 2 2 Survived
B088 52 M 34 B pos 18.1 233000 33 4 0 3 0 4 Both App and Inapp 1 3 2 1 Survived
B091 17 F 27 B pos 16.4 239000 35 4 0 8 0 4 Inapp. Txn 0 4 2 6 Survived
B092 26 M 17 O pos 9.2 414000 32 7 0 2 0 7 Both App and Inapp 6 1 2 0 Survived
B093 29 F 20 B pos 8 226000 36 1 2 2 0 3 App. Txn 3 0 2 0 Survived
B094 30 M 31 O pos 14 179000 34 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B095 26 M 20 O pos 15 83000 31 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B097 23 M 15 B pos 11 278000 3 3 0 1 0 3 Inapp. Txn 0 3 0 1 Survived
B098 23 F 23 O pos 12.1 128000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B099 27 F 28 B pos 15.8 320000 31 5 5 9 0 10 Both App and Inapp 8 2 4 5 Survived
B100 20 F 30 B pos 14 230000 32 1 1 3 0 2 App. Txn 2 0 2 1 Survived
B101 48 F 15 O pos 11.2 166000 32 1 0 2 0 1 App. Txn 1 0 0 2 Survived
B102 37 M 35 O pos 16.8 90000 34 4 0 5 0 4 Both App and Inapp 3 1 0 5 Survived
B103 35 M 30 B pos 16.4 80000 35 0 0 2 0 0 No RBC Txn 0 0 0 2 Survived
B104 27 M 20 O pos 11.4 173000 36 1 0 3 0 1 App. Txn 1 0 2 1 Survived
B105 45 M 25 B pos 14.8 220000 35 1 0 2 0 1 Inapp. Txn 0 1 0 2 Survived
B106 25 F 27 B pos 8.9 243000 34 4 1 3 0 5 Both App and Inapp 4 1 2 1 Survived
B107 25 M 20 B pos 13.9 158000 32 0 2 3 0 2 Inapp. Txn 0 2 0 3 Survived
B108 38 F 30 B pos 8.7 240000 35 5 2 0 0 7 Both App and Inapp 5 2 0 0 Survived
B109 27 F 40 O pos 12 130000 33 3 0 7 0 3 Inapp. Txn 0 3 2 5 Survived
B111 26 F 28 O pos 12 108000 33 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B112 39 F 20 O pos 13 204000 34 2 1 8 0 3 App. Txn 3 0 3 5 Survived
B113 70 F 37 B pos 10 171000 35 0 1 3 0 1 App. Txn 1 0 2 1 Survived
B114 30 M 35 O pos 14.6 156000 31 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B115 34 M 40 B pos 13.5 100000 32 2 0 6 0 2 App. Txn 2 0 2 4 Survived
B116 34 M 31 O pos 14.8 124000 33 2 0 2 0 2 Inapp. Txn 0 2 0 2 Survived
B118 22 F 15 O pos 10.6 130000 34 1 0 6 0 1 App. Txn 1 0 2 4 Survived
B119 24 M 15 B pos 15.7 182000 35 0 1 3 0 1 App. Txn 1 0 2 1 Survived
B120 40 F 35 O pos 9.6 235000 35 1 3 5 0 4 App. Txn 4 0 2 3 Survived
B122 50 M 37 O pos 13 160000 36 0 1 2 0 1 App. Txn 1 0 2 0 Survived
B123 20 M 15 A pos 13.6 271000 36 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B124 55 M 16 B pos 5.6 178000 35 5 5 0 0 10 Both App and Inapp 9 1 0 0 Survived
B125 42 M 18 O pos 9.8 183000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B126 50 M 30 A pos 10.6 170000 35 1 0 6 0 1 Inapp. Txn 0 1 4 2 Survived
B127 65 M 25 A pos 13.7 186000 35 1 0 3 0 1 App. Txn 1 0 2 1 Survived
B128 45 F 24 A pos 10.7 139000 36 6 0 5 0 6 Both App and Inapp 5 1 2 3 Survived
B129 26 F 29 AB pos 10.7 219000 37 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B130 42 M 18 O pos 9.8 183000 38 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B131 25 F 18 B pos 11.4 51000 39 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B132 44 M 38 B pos 10 243000 34 2 0 6 0 2 App. Txn 2 0 3 3 Survived
B133 35 M 27 O pos 12 173000 33 1 0 4 0 1 Inapp. Txn 0 1 2 2 Survived
B134 40 M 20 A pos 17.1 175000 34 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B135 28 F 22 A pos 11 145000 35 1 0 2 0 1 App. Txn 1 0 2 0 Survived
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B001 45 M 18 B pos 12.9 155000 32 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B002 61 M 15 B pos 10.7 330000 34 1 0 2 0 1 App. Txn 1 0 0 2 Survived
B003 38 M 25 A pos 15 276000 32 1 0 8 0 1 Inapp. Txn 0 1 4 4 Survived
B004 20 M 27 O pos 16.1 209000 33 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B005 65 M 27 B pos 13 94000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B006 26 M 23 B pos 17 145000 37 17 8 7 1 25 Both App and Inapp 23 2 4 3 Survived
B007 30 F 38 O pos 13.9 220000 38 7 0 8 0 7 Both App and Inapp 6 1 3 5 Survived
B010 35 M 39 A pos 16 165000 32 1 0 0 0 1 Inapp. Txn 0 1 0 0 Survived
B011 72 F 21 O pos 10.1 197000 36 0 2 1 0 2 App. Txn 2 0 0 1 Survived
B012 30 F 27 O pos 13 100000 39 3 3 3 0 6 App. Txn 6 0 0 3 Survived
B013 25 F 33 O pos 9.3 209000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B014 16 F 15 B pos 10.8 179000 36 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B015 25 F 26 B pos 13.1 122000 32 3 0 2 0 3 App. Txn 3 0 0 2 Survived
B016 35 M 40 O pos 14.1 79000 39 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B017 33 M 25 O pos 11.3 129000 34 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B018 32 M 27 O pos 12 110000 33 0 0 0 0 0 No RBC Txn 0 0 0 0 Survived
B019 29 M 17 B pos 13 495000 31 3 0 0 0 3 App. Txn 3 0 0 0 Survived
B020 46 M 20 A pos 16 141000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B021 22 M 15 O pos 14.5 127000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B022 42 F 17 B pos 14.8 276000 31 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B024 27 M 28 O pos 12.4 366000 32 0 0 2 0 0 No RBC Txn 0 0 0 2 Survived
B025 23 F 20 B pos 13 249000 34 2 2 1 0 4 Both App and Inapp 3 1 0 1 Survived
B027 29 F 32 AB pos 9.9 300000 36 5 0 3 0 5 App. Txn 5 0 2 1 Survived
B028 46 M 18 B pos 8.5 387000 37 5 1 0 0 6 Both App and Inapp 5 1 0 0 Survived
B029 40 M 27 B pos 14 239000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B030 19 M 36 AB pos 10.1 179000 33 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B031 40 M 19 O pos 9 159000 32 2 2 0 0 4 App. Txn 4 0 0 0 Survived
B032 40 M 30 A pos 12.5 112000 37 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B033 24 M 31 B pos 15.1 222000 35 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B034 27 F 27 O pos 14.4 278000 34 1 0 4 0 1 App. Txn 1 0 2 2 Survived
B035 28 F 26 B pos 11 251000 34 3 1 2 0 4 App. Txn 4 0 2 0 Survived
B036 21 F 28 A pos 14.3 265000 35 1 1 6 0 2 App. Txn 2 0 4 2 Survived
B037 55 F 25 A pos 12 186000 33 3 0 10 0 3 App. Txn 3 0 4 6 Survived
B038 50 F 20 B pos 14 33000 38 2 1 2 0 3 App. Txn 3 0 0 2 Survived
B039 17 F 21 O pos 13.9 445000 32 3 0 2 0 3 Both App and Inapp 2 1 2 0 Survived
B040 55 M 23 B pos 9.2 106000 33 4 1 6 0 5 App. Txn 5 0 2 4 Survived
B041 37 M 33 B pos 11.4 192000 34 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B042 34 M 34 O pos 16 177000 35 4 2 3 0 6 Both App and Inapp 3 3 2 1 Survived
B043 33 M 22 O pos 15.6 164000 35 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B044 60 F 29 B pos 8 151000 36 2 2 4 0 4 App. Txn 4 0 2 2 Survived
B046 38 F 32 O pos 11 259000 34 6 3 5 0 9 Both App and Inapp 5 4 2 3 Survived
B048 24 F 36 O pos 12 34000 38 4 4 5 0 8 App. Txn 8 0 2 3 Survived
B049 28 F 30 B pos 11.4 125000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B050 29 F 30 O pos 13 217000 34 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B051 60 M 26 O pos 12.6 209000 35 1 2 3 0 3 App. Txn 3 0 2 1 Survived
B052 48 M 23 O pos 15 442000 38 0 2 2 0 2 Inapp. Txn 0 2 2 0 Survived
B053 54 M 24 B pos 11 341000 38 1 0 4 0 1 Inapp. Txn 0 1 2 2 Survived
B054 40 F 40 B pos 13.3 349000 37 2 0 2 0 2 App. Txn 2 0 2 0 Survived
B055 39 F 31 A pos 12.9 212000 36 3 0 5 0 3 Both App and Inapp 1 2 3 2 Survived
B056 38 F 33 B pos 13.5 221000 37 3 1 5 0 4 Both App and Inapp 3 1 3 2 Survived
B057 45 M 15 A pos 14.5 194000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B058 50 M 25 O pos 15 131000 35 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B059 31 M 17 O neg 14.3 190000 36 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B060 28 F 25 O pos 8.5 285000 37 0 1 0 0 1 App. Txn 1 0 0 0 Survived
B061 24 F 32 A neg 11.2 237000 38 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B062 61 F 20 O pos 11.2 54000 36 0 0 3 0 0 No RBC Txn 0 0 2 1 Survived
B063 25 F 25 B pos 14.3 138000 33 4 1 5 0 5 App. Txn 5 0 0 5 Survived
B064 18 F 25 B pos 15.9 572000 32 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B065 29 F 34 B pos 11.9 297000 34 4 4 11 0 8 App. Txn 8 0 4 7 Survived
B067 40 M 20 B pos 10.8 483000 37 4 3 6 0 7 App. Txn 7 0 3 3 Survived
B068 36 F 33 B pos 12.7 273000 35 2 0 6 0 2 App. Txn 2 0 3 3 Survived
B069 45 M 18 A pos 11.1 448000 32 2 2 4 0 4 Inapp. Txn 0 4 0 4 Survived
B070 26 F 26 AB pos 10.5 100000 33 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B071 81 F 27 O neg 6.6 174000 34 0 2 2 0 2 App. Txn 2 0 2 0 Survived
B072 26 F 30 B pos 11.5 236000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B073 40 F 30 B neg 10.7 111000 34 2 1 2 0 3 Both App and Inapp 2 1 2 0 Survived
B074 19 F 20 AB pos 9.5 210000 33 4 0 6 0 4 Both App and Inapp 2 2 2 4 Survived
B075 26 F 26 O neg 13.2 190000 33 2 1 8 0 3 Both App and Inapp 2 1 3 5 Survived
B076 23 M 19 A pos 12 154000 34 7 1 8 0 8 Both App and Inapp 2 6 2 6 Survived
B077 32 F 25 O pos 14.6 290000 34 1 0 4 0 1 App. Txn 1 0 2 2 Survived
B078 38 M 27 B neg 15.9 390000 32 3 0 10 0 3 Both App and Inapp 2 1 6 4 Survived
B079 33 M 36 A pos 16.5 256000 33 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B080 18 M 38 O pos 7.4 264000 33 1 3 2 0 4 App. Txn 4 0 2 0 Survived
B081 30 F 32 O pos 9.7 103000 34 4 0 8 0 4 App. Txn 4 0 4 4 Survived
B082 42 M 20 O pos 16.3 277000 32 1 0 4 0 1 App. Txn 1 0 0 4 Survived
B083 22 M 31 A pos 15.4 95000 31 0 2 8 0 2 Both App and Inapp 1 1 2 6 Survived
B084 27 M 30 O pos 12.4 157000 32 5 0 8 0 5 Both App and Inapp 4 1 2 6 Survived
B085 40 M 19 A pos 12 146000 33 7 1 7 0 8 App. Txn 8 0 4 3 Survived
B086 30 M 30 O pos 14.3 132000 32 2 0 8 0 2 Both App and Inapp 1 1 4 4 Survived
B087 35 M 22 A pos 12.3 660000 31 2 0 4 0 2 App. Txn 2 0 2 2 Survived
B088 52 M 34 B pos 18.1 233000 33 4 0 3 0 4 Both App and Inapp 1 3 2 1 Survived
B091 17 F 27 B pos 16.4 239000 35 4 0 8 0 4 Inapp. Txn 0 4 2 6 Survived
B092 26 M 17 O pos 9.2 414000 32 7 0 2 0 7 Both App and Inapp 6 1 2 0 Survived
B093 29 F 20 B pos 8 226000 36 1 2 2 0 3 App. Txn 3 0 2 0 Survived
B094 30 M 31 O pos 14 179000 34 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B095 26 M 20 O pos 15 83000 31 1 0 2 0 1 Inapp. Txn 0 1 2 0 Survived
B097 23 M 15 B pos 11 278000 3 3 0 1 0 3 Inapp. Txn 0 3 0 1 Survived
B098 23 F 23 O pos 12.1 128000 35 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B099 27 F 28 B pos 15.8 320000 31 5 5 9 0 10 Both App and Inapp 8 2 4 5 Survived
B100 20 F 30 B pos 14 230000 32 1 1 3 0 2 App. Txn 2 0 2 1 Survived
B101 48 F 15 O pos 11.2 166000 32 1 0 2 0 1 App. Txn 1 0 0 2 Survived
B102 37 M 35 O pos 16.8 90000 34 4 0 5 0 4 Both App and Inapp 3 1 0 5 Survived
B103 35 M 30 B pos 16.4 80000 35 0 0 2 0 0 No RBC Txn 0 0 0 2 Survived
B104 27 M 20 O pos 11.4 173000 36 1 0 3 0 1 App. Txn 1 0 2 1 Survived
B105 45 M 25 B pos 14.8 220000 35 1 0 2 0 1 Inapp. Txn 0 1 0 2 Survived
B106 25 F 27 B pos 8.9 243000 34 4 1 3 0 5 Both App and Inapp 4 1 2 1 Survived
B107 25 M 20 B pos 13.9 158000 32 0 2 3 0 2 Inapp. Txn 0 2 0 3 Survived
B108 38 F 30 B pos 8.7 240000 35 5 2 0 0 7 Both App and Inapp 5 2 0 0 Survived
B109 27 F 40 O pos 12 130000 33 3 0 7 0 3 Inapp. Txn 0 3 2 5 Survived
B111 26 F 28 O pos 12 108000 33 0 0 6 0 0 No RBC Txn 0 0 2 4 Survived
B112 39 F 20 O pos 13 204000 34 2 1 8 0 3 App. Txn 3 0 3 5 Survived
B113 70 F 37 B pos 10 171000 35 0 1 3 0 1 App. Txn 1 0 2 1 Survived
B114 30 M 35 O pos 14.6 156000 31 0 0 1 0 0 No RBC Txn 0 0 0 1 Survived
B115 34 M 40 B pos 13.5 100000 32 2 0 6 0 2 App. Txn 2 0 2 4 Survived
B116 34 M 31 O pos 14.8 124000 33 2 0 2 0 2 Inapp. Txn 0 2 0 2 Survived
B118 22 F 15 O pos 10.6 130000 34 1 0 6 0 1 App. Txn 1 0 2 4 Survived
B119 24 M 15 B pos 15.7 182000 35 0 1 3 0 1 App. Txn 1 0 2 1 Survived
B120 40 F 35 O pos 9.6 235000 35 1 3 5 0 4 App. Txn 4 0 2 3 Survived
B122 50 M 37 O pos 13 160000 36 0 1 2 0 1 App. Txn 1 0 2 0 Survived
B123 20 M 15 A pos 13.6 271000 36 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B124 55 M 16 B pos 5.6 178000 35 5 5 0 0 10 Both App and Inapp 9 1 0 0 Survived
B125 42 M 18 O pos 9.8 183000 36 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B126 50 M 30 A pos 10.6 170000 35 1 0 6 0 1 Inapp. Txn 0 1 4 2 Survived
B127 65 M 25 A pos 13.7 186000 35 1 0 3 0 1 App. Txn 1 0 2 1 Survived
B128 45 F 24 A pos 10.7 139000 36 6 0 5 0 6 Both App and Inapp 5 1 2 3 Survived
B129 26 F 29 AB pos 10.7 219000 37 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B130 42 M 18 O pos 9.8 183000 38 0 0 4 0 0 No RBC Txn 0 0 2 2 Survived
B131 25 F 18 B pos 11.4 51000 39 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B132 44 M 38 B pos 10 243000 34 2 0 6 0 2 App. Txn 2 0 3 3 Survived
B133 35 M 27 O pos 12 173000 33 1 0 4 0 1 Inapp. Txn 0 1 2 2 Survived
B134 40 M 20 A pos 17.1 175000 34 0 0 2 0 0 No RBC Txn 0 0 2 0 Survived
B135 28 F 22 A pos 11 145000 35 1 0 2 0 1 App. Txn 1 0 2 0 Survived
